XEROGRAPHIC LASER IMAGES CORP /DE/
10KSB, 1997-03-19
COMPUTER PERIPHERAL EQUIPMENT, NEC
Previous: DEFINED ASSET FUNDS MUN INVT TR FD AMT MON PYMT SER 17, 485BPOS, 1997-03-19
Next: XEROGRAPHIC LASER IMAGES CORP /DE/, 5, 1997-03-19




                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                   FORM 10-KSB

(Mark One)

 (X)  ANNUAL REPORT  PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES  EXCHANGE
      ACT OF 1934 (FEE REQUIRED)

      For the fiscal year ended December 31, 1996


                                       OR

 ( )  TRANSITION  REPORT  PURSUANT  TO  SECTION  13 OR 15(d)  OF THE  SECURITIES
      EXCHANGE ACT OF 1934 (NO FEE REQUIRED)

For the transition period from             to
                              ------------

Commission file number 1-11236

                      XEROGRAPHIC LASER IMAGES CORPORATION
                 (Name of Small Business Issuer in Its charter)

          Delaware                                51-0319174
- ----------------------------          ------------------------------------
(State or other jurisdiction          (I.R.S. Employer Identification No.)
of incorporation or organization)

101 Billerica Avenue, 5 Billerica Park
         North Billerica, MA                                      01862
         -------------------                                    ---------
(Address of principal executive offices)                        (Zip Code)

                                 (508) 670-5999
               --------------------------------------------------
              (Registrant's telephone number, including area code)

 Securities registered under Section 12 (b) of the Exchange Act:

                           Not Applicable


Securities registered pursuant to Section 12(g) of the Exchange Act:

Title of Each Class

Common Stock, $.01 par value
Redeemable Common Stock Purchase Warrants
Series A Convertible Preferred Stock, $.01 par value
Class A Redeemable Common Stock Purchase Warrants

     Check whether the issuer: (1) has filed all reports required to be filed by
Section 13 or 15(d) of the  Securities  Exchange  Act of 1934 during the past 12
months (or for such shorter period that the registrant was required to file such
reports),  and (2) has been subject to such filing  requirement  for the past 90
days. (1) Yes X  No   (2) Yes X  No
             ---   ---       ---   ---








      Check if there is no disclosure  of delinquent  filers in response to Item
405 of  Regulation  S-B  contained  in  this  form,  and no  disclosure  will be
contained,  to the  best of  registrant's  knowledge,  in  definitive  proxy  or
information statements incorporated by reference in Part III of this Form 10-KSB
or any amendment to this Form 10-KSB [ ]

         The issuer's  revenues for its fiscal year ended December 31, 1996 were
$898,618.

         As of March 12, 1997,  1,778,646 shares of Common Stock, $.01 par value
per share,  and 315,238 shares of Series A Preferred  Stock,  $.01 par value per
share, were outstanding. The aggregate market value, held by non-affiliates,  of
shares of the Common and Series A Convertible  Preferred  Stock,  based upon the
average  of  the  bid  and  ask  prices  for  such  stock  on  that  date,  were
approximately $83,830 and $3,102 respectively.








ITEM 1. DESCRIPTION OF BUSINESS



General

Founded in 1989,  Xerographic Laser Images  Corporation ("XLI" or the "Company")
designs,  develops and markets  high-performance  hardware and software products
primarily  for the desktop  image  processing  market.  XLI's mission is to be a
leading  provider of high  technology  products for printers,  digital  copiers,
scanners, multi-function devices, and fax systems.

XLI's  proprietary  precision dot positioning  technology  enables  high-quality
text, line-art graphics and photographic images to be generated at low costs and
high speeds using standard and inexpensive printing devices.
The Company's technology is used in the following applications:

      o High quality text and line art edge enhancement 
      o Life-like  photographs with gray scale rendition 
      o Digital copier functions o Hi-Definition Fax 
      o High Quality Color Images on  inexpensive  color laser  printers 
      o Product solutions for both laser and inkjet print engines
      o High performance image enhancement and modulation for demand 
        printing applications
      o Application Specific Integrated Circuits (ASIC) and Core Modules 
        to meet customer requirements and costs



PRODUCTS

The Company provides its proprietary precision dot positioning technology in the
form of Application Specific Integrated Circuits ("ASICs") and VHDL Core Modules
(design  modules  that can be used by Company's  customers to develop  their own
ASICs that incorporate multiple  applications,  including the Company's).  These
ASICs are  incorporated by the Company's  customers into controller  boards that
are imbedded into the printing device as an integral component.



ASIC & VHDL Developments

The Company's initial ASIC  co-developed  with Samsung  Electronics as part of a
1995  development  agreement,   was  completed  in  early  1996.  This  ASIC  is
appropriate for both printer and  multi-function  



                                       3




applications.  As part of it's agreement with Samsung, XLI retained the right to
sell this ASIC in the market.  A second  agreement has been reached with Samsung
to develop the next generation ASIC using the latest XLI enhancement technology.
The first ASIC using this latest XLI  technology is expected to be available for
sale in the second or third quarter of 1997.

The Company  entered into two  licensing  and royalty  agreements  with Pipeline
Associates, Inc. in 1996. The first agreement allows Pipeline to incorporate XLI
enhancement  technology  into certain  Pipeline  product  offerings.  The second
agreement is a  co-development  agreement for a new  "Superchip" for anticipated
release in 1997.  Both  Pipeline and XLI will have the right to market this ASIC
with XLI receiving royalty payments on Pipeline sales.

In late 1996,  XLI and  Xionics  Document  Technologies,  Inc.,  entered  into a
licensing and royalty  agreement  pursuant to which Xionics may  incorporate XLI
technology  into  certain  Xionics  product  offerings.  Xionics is a controller
design  supplier  to the OEM  printer  market.  Also in late 1996 XLI  reached a
licensing and royalty  agreement with a Japanese printer  manufacturer to supply
the  Company's  technology in the form of VHDL for  incorporation  into a custom
ASIC.

The licensing of XLI  enhancement  technology in the form of ASICs and VHDL core
modules is expected to be the major  development and sales focus for the Company
for the foreseeable future.

Laserpix and Photojet Boards

The Company's  Laserpix and Photojet board  products are sold primarily  through
Value  Added  Resellers  (VARs) in  specialty  medical  and  scientific  imaging
markets. The Company's  fingerprinting products consist of an XLI Laserpix board
with special features.  As resolutions of standard laser printers have improved,
the revenue  from this  market  segment  has been  gradually  becoming a smaller
portion  of the  total XLI  business.  There  are no new  product  introductions
planned for the board  business as the Company  continues to focus its attention
on the mass market OEM printer enhancement market.

Flat Panel Display Scaling/Enhancement

XLI reached an agreement  with Samsung  Electronics  in late 1996 to use the XLI
technology  to  improve  the   scaling/enhancement  of  flat  panel  stand-alone
displays.  There  can  be  no  assurance  that  the  Company  will  be  able  to
successfully apply its technology to flat panel displays.




PRODUCT DEVELOPMENT

Through  development  partnerships  with  companies  in the Far  East and in the
United  States,  XLI is  developing  a series of ASICs for the OEM




                                       4




printer and printer  controller  market.  These new ASICs are being  designed to
incorporate a digital precision  modulator that requires no external  components
or high speed clocks. The edge enhancement  (including fax enhancement which was
added  this  past  year)  and  modulator  technology  is  expected  to form  the
foundation for other chip offerings in the next few years.



COMPETITION


XLI's primary competitors in providing printing enhancement  solutions have been
DP-Tek Development Corp., LLC and Destiny Technology Corporation.  The Company's
most  significant  competitor  had been DP-Tek.  Dp-Tek  offered both ASIC's and
Virtual  Hardware Design  Language (VHDL) core technology to original  equipment
manufacturers  ("OEMs"). In July 1996, Hewlett Packard acquired DP-Tek and it is
anticipated  that Hewlett  Packard will not renew the DP-Tek licenses with OEMs,
as such  licenses  expire.  The  DP-Tek  OEMs are now  looking  for  alternative
enhancement technology (either purchased or internally developed) which presents
a wider market opportunity for XLI and other technology providers.

The Company's focus is on providing  leading edge image  enhancement  technology
that will  effectively  compete with that offered by Hewlett  Packard in its own
office products. XLI does not consider Hewlett Packard as its direct competitor,
but as the market  leader who is  establishing  the  functionality  and  quality
requirements that its competitors (the Company's  customers) must offer in order
to compete.

Destiny, XLI's main independent  competitor currently,  has made in-roads in the
area  of low  cost  ASIC  chips  that  typically  produce  a low  level  of edge
enhancement for text. At this time Destiny is not considered a competitor in the
area of high quality text and photo image enhancement.

In addition to Destiny,  in-house  development  groups at printer  manufacturers
such at Minolta and Canon also provide  competition  for the  Company.  Although
these companies do not typically license their internally  developed  technology
to other printer manufacturers,  XLI must have technology  demonstrably superior
in order to sell to these companies.

XLI believes its products  have  advantages  that are  attractive  to customers.
First,  XLI's  products can provide  high  quality edge (fax,  text and line art
edges) and photo image  enhancement,  using the Company's  proprietary  fine dot
positioning  technology for optimal  quality.  Second,  XLI's photo  enhancement
technology (single-bit grayscale) requirements,  as compared to its competitors'
products, provides both increased speed and reduced memory requirements, leading
to lower costs and shorter time to market for the OEM customer.




                                      5




SALES AND MARKETING

In the United States,  the Company sells its board level products  through Value
Added Resellers (VAR's), OEM's, dealers and directly to end users. The Company's
boards  are sold  primarily  for  medical  and  scientific  imaging  where  high
resolution  is required.  ASIC and VHDL Core Module  sales are made  directly to
OEMs.  XLI has recently  retained an  independent  sales agent and consultant to
focus principally on major accounts in the United States.

The Company markets its products outside the United States through international
distributors pursuant to distribution agreements covering specified territories.
XLI has recently  engaged a sales agent in Japan  specifically for VHDL and ASIC
sales.

XLI will continue to market, in addition to its offering in ASIC form, VHDL Core
Modules  (design modules that can be used by an OEM to develop its own ASIC) and
some software products  principally for the OEM and VAR markets.  XLI also plans
to provide its existing board and software  products to selective VAR markets in
the scientific and specialty printing markets.


CUSTOMER SUPPORT

         XLI's LaserPix products are user installed with the aid of installation
manuals  provided  by the  Company.  OEM,  VAR and  direct  customer  support is
provided by the Company's full-time technical support telephone  specialists who
are available  during its normal  business hours and who have been trained on PC
products  and on most  popular  software  applications  used  by its  customers.
Because  of  features  built  into  LaserPix  and  PhotoJet  for ease of use and
installation,  this level of support has to date been  satisfactory to users and
resellers  and the  Company  expects  this level of support  to  continue  to be
sufficient in the future.

         The Company provides a one-year factory  repair-or-replace  warranty on
all  hardware.  Out-of-warranty  repair is done at the  Company  on a  fixed-fee
basis.


PATENTS AND PROPRIETARY INFORMATION

The  Company  relies on a  variety  of  methods  to  protect  its  products  and
technology,  including patent, trademark, copyright and trade secret protection.
The Company believes that patent and trade secret protection for its products is
important to its  ultimate  success.  The Company has been  awarded U.S.  Patent
Number  5,109,283,  which covers its  innovative  method of modulating the laser
device  found in desktop  printers  to yield  high-quality  text,  graphics  and
photographic  images



                                      6




and U.S. patent number 5,122,883,  which covers the application of the Company's
technology to high-speed  laser printers capable of output of over 100 pages per
minute. The Company has applied for protection for these patents in Korea, Japan
and major western  European  countries.  In 1996 the Company filed three patents
covering new technology  developed by the Company;  a single-pass  color engine,
color and monochrome edge enhancement, and an all digital modulator suitable for
integrated  circuit  implementation.  The Company intends to continue to protect
its technical  innovations both domestically and internationally  through patent
filings. To protect its trade secrets,  proprietary  software and know-how,  the
Company  requires that all employees,  key resellers and suppliers,  consultants
and  licensees,  sign  nondisclosure  agreements.  The  Company  also  relies on
copyright  protection  for  its  software  and  documentation.   LaserPix  is  a
registered trademark of the Company.

         Although the Company  believes that patent  protection for its products
is important to its ultimate success, no assurance can be given that any patents
granted will be  enforceable or provide the Company with  meaningful  protection
from competitors.  Even if a competitor were to infringe the Company's  patents,
the costs of enforcing its patent rights may be substantial or even prohibitive.
In addition, there can be no assurance that the Company's proposed products will
not  infringe the patent  rights of others.  The Company may be forced to expend
substantial  resources  if the Company is  required  to defend  against any such
infringement  claims.  Furthermore,  there can be no assurance  that the Company
will be able to  maintain  the  secrecy  of any of its  proprietary  technology,
know-how  or  trade  secrets  or that  others  will  not  independently  develop
substantially equivalent technology.

    The core  technology for XLI was invented by Dr. Adam L. Carley (the "Carley
Technology"), a founder, stockholder and director of the Company. Dr. Carley and
the Carley Corporation, a company controlled by Dr. Carley, have assigned to the
Company  all  rights  to the  Carley  Technology  held  by him  and  the  Carley
Corporation in return for Common Stock and certain royalties based upon revenues
derived by the  Company  from the Carley  Technology.  This  royalty  obligation
terminates  upon payment to Carley by the Company of a cumulative  total of $2.4
million. To date, the Company has paid $414,210 pursuant to this agreement.  The
Company has sublicensed to the Carley Corporation the exclusive right to use, on
a royalty-free  basis,  the Carley  Technology for retail  services in locations
such as stores,  kiosks and booths for  purposes  including  but not  limited to
picture taking and reproduction.

PERSONNEL

    As of March 10,  1997,  the  Company  employed  9 people,  3 of whom were in
research and  development,  1 in marketing  and sales,  2 in  manufacturing  and
product service, and 3 in finance and administration. The Company uses part-time
technical  contractors,  as needed,  to augment its full-time  staff. Due to the
Company's  limited cash flow,  certain key personnel have been receiving reduced
cash  compensation  and have been, and will continue to be, issued stock




                                       7




options and shares of Common Stock of the Company in lieu of cash compensation.



ITEM 2.  DESCRIPTION OF PROPERTY

    The Company's  administrative,  sales, marketing,  research and development,
and product testing facility is located in North Billerica,  Massachusetts.  The
facility  consists  of  approximately  4,850  square  feet and is  leased by the
Company  from an  unaffiliated  party for  $3,293  per month  under a lease that
expires in April 1999.


ITEM 3.   LEGAL PROCEEDINGS

    The Company is not presently involved in any legal proceedings.


ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

    No matters were  submitted to a vote of security  holders  during the fourth
quarter of fiscal 1996.


ITEM 5.  MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

    The Company's  Common stock is currently traded on the NASDAQ Bulletin Board
under the symbol "XLCC," and the Company's Series A Preferred Stock is traded on
NASDAQ Bulletin Board under the symbol "XLCCP".  On January 4, 1995, the Company
stock was  delisted  from the  NASDAQ  Small  Cap  market as it did not meet the
minimum requirement for maintaining listing.

    The  following  table sets forth the range of high and low prices  quoted on
NASDAQ for the Common Stock for the periods  indicated.  Such quotations reflect
inter-dealer prices, without retail mark-up,  mark-down or commission and do not
necessarily represent actual transactions.

                                      Common Stock

                                     High      Low
                                     Bid       Bid
                                     Price     Price

1996

First Quarter......................  $0.10     $0.001
Second Quarter.....................  $0.1875   $0.001
Third Quarter......................  $0.4375   $0.125
Fourth Quarter.....................  $0.4375   $0.125


1995



                                       8




First Quarter......................  $0.12     $0.02
Second Quarter.....................  $0.2815   $0.02
Third Quarter......................  $0.03125  $0.02
Fourth Quarter.....................  $0.02     $0.001



    On March 12, 1997, the closing sale price of the Company's  Common Stock was
$.09375 per share and there were 225 shareholders of record.



                                 DIVIDEND POLICY

    The  Company  has  never  paid any cash  dividends  and does not  anticipate
payment of cash  dividends  on the  Company's  Common  Stock in the  foreseeable
future.  Under  Delaware  Corporation  Law,  dividends  may be paid  only out of
legally  available funds as proscribed by statute,  subject to the discretion of
the Company's Board of Directors.


ITEM 6 MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

    The Private  Securities  Litigation  Reform Act of 1995 contains safe harbor
provisions   regarding   forward-looking   statements.   Except  for  historical
information contained herein, the matters discussed in the Liquidity and Capital
Resources  section below contain potential risks and  uncertainties,  including,
without  limitation,  risks  related to the  Company's  ability to  successfully
develop,  test, produce and market its proposed  products,  identify and attract
partners to help  commercialize the Company's  products;  attract and retain key
employees;   obtain   meaningful   patent  protection  to  cover  the  Company's
proprietary    technology;    raise   capital   for   future    operations   and
commercialization  of its products;  and  successfully  respond to technological
changes in the  marketplace.  The Company will need to attract partners in order
to exploit its products,  and there can be no assurance that the Company will be
successful in attracting  such  partners.  Additional  information  on potential
factors which could affect the Company's  financial  results are included in the
Company's public filings with the Securities and Exchange Commission.

GENERAL

In 1996 the Company  continued  its  efforts to minimize  expenses to match near
term  expected  revenues.  The  Company  continues  to focus on the  design  and
development of ASIC, VHDL and software  products for the OEM printer and printer
controller  market.  During  1996 the  Company  completed  the  VHDL  for  XLI's
Superchip that incorporates all of the Company's current enhancement  technology
into one chip design. This VHDL is the core of XLI's current offerings to OEM's.
The Company hopes to increase revenue through additional corporate alliances and
additional licensing of the Superchip technology.  The Company also plans to add
additional  engineering  resources  in 1997 in order to meet



                                       9




the demands from existing and anticipated  OEM  agreements.  This will result in
increased  research and development  costs and may negatively  affect cash flow.
For the fiscal year ended  December  31, 1996,  the Company had a positive  cash
flow from operations of $64,316,

The Company has no current  plans to  undertake  a debt or equity  financing  in
1997.  Funds for  development  efforts  will come from  current  or  anticipated
licensing  and royalty  fees.  If the  Company is unable to fund its  operations
through cash flow,  the Company's  development  efforts and  operations  will be
materially adversely effected.

The following are key areas where progress has been made during the past year:

o   Maintained  the reduced  levels of expenses and personnel  that was put into
    place during 1995.

o   Continued stock and option grants to retain critical staffing levels.

o   Continued focus on mass market product  development with strategic  partners
    to maximize technology leverage and minimize expense.

o   Successfully completed the first ASIC development for Samsung.

o   Entered into a second ASIC development with Samsung.

o   Signed major  license  agreements  with Pipeline  Associates,  Xionics and a
    major Japanese OEM.

o   Negotiated  agreement  with Pipeline for the  development  and production of
    Superchip ---- XLI's next generation enhancement chip.

o   Released VHDL for a complete  enhancement  product for OEM's to  incorporate
    this technology into their own chip developments.

o   Signed a license  agreement  with  Samsung for  display  scaling/enhancement
    technology development.

o   Patents filed for monochrome and color edge  enhancement plus an all digital
    precision modulator.

o   Completed fax and single-bit gray scale enhancement algorithms.

o   Filed a patent for a unique single-pass color laser engine design concept.

o   Continued  de-emphasis of the XLI board products and placed all  engineering
    development  on the core laser  enhancement  technology  for OEM printer and
    printer controller manufacturers.

The  following  table sets  forth,  for the  periods  indicated,  statements  of
operation data of the Company expressed as a percentage of revenues.



                                       10








                                        Years Ended December 31,
                                     1996        1995       1994



Revenue                              100%        100%       100%

Cost of Revenue                       29%         45%       118%

Research and Development              32%         30%        30%

OEM Development                        0%          0%        36%

Selling and Marketing                  5%         11%        59%

General and Administrative            51%         33%        76%

Loss from Operations                (16)%       (19)%     (219)%

Other Income (Expense)               (5)%        (2)%      (13)%

Net Loss                            (21)%       (21)%     (232)%




RESULTS OF OPERATIONS

YEAR ENDED DECEMBER 31, 1996 COMPARED TO YEAR ENDED DECEMBER 31, 1995.

         Revenue.  Revenue  for the fiscal  year  ended  December  31,  1996 was
$898,618 as compared to $1,097,550  for the fiscal year ended December 31, 1995,
a decrease of $198,932 or 18%.  Product board revenues for the fiscal year ended
December  31, 1996 were  $200,368 as compared to $397,550  for fiscal year ended
December  31, 1995, a decrease of $197,182 or  approximately  50%.  Contract and
license  revenue for the fiscal  year ended  December  31, 1996 was  $698,250 as
compared to $700,000 for the fiscal year ended  December 31, 1995.  The decrease
in product revenue was primarily  attributable to a discontinuation of the board
product lines.

In 1996, the Company  entered into two cooperative  development  agreements with
Samsung  Electronics  Co.  License  agreements  were also signed  with  Pipeline
Associates  and Xionics  Document  Technologies.  These  agreements  resulted in
contract and license revenues of $698,250.  The Company anticipates that it will
enter into additional cooperative development relationships in 1997.

         Cost of Revenue. Cost of revenue for the fiscal year ended December 31,
1996 was  $258,440 or 29% of revenue,  as compared to $496,866 or 45% of revenue
for the fiscal  year ended  December  31,  1995,  a decrease  of  $238,426.  The
decrease  was due mostly to the 50%




                                       11



drop in product revenue and included in the cost of revenue for fiscal year 1996
are inventory write-offs of $30,516.


         Research  and  Development.  Research and  development  expense for the
fiscal year ended  December  31, 1996 was $287,748 or 32% of revenue as compared
to $331,279 or 30% of revenue for the fiscal year ended  December 31, 1995.  The
decrease  in 1996  of  $43,531  was  primarily  attributable  to a  decrease  in
sub-contract   work  associated  with  the  Company's   agreement  with  Samsung
Electronics.  The Company's ongoing engineering  emphasis will continue to be on
the development of ASICs.


         Selling and  Marketing.  Selling and marketing  expenses for the fiscal
year ended  December  31,  1996 were  $42,942 or 5% of  revenue as  compared  to
$117,896 or 11% of revenue for the year ended December 31, 1995. The decrease of
$74,954 was primarily  attributable to use of commissioned  personnel in lieu of
salaried personnel.

         General and  Administrative.  General and administrative  expenses were
$456,156  or 51% of revenue  for the  fiscal  year ended  December  31,  1996 as
compared to $358,040  or 33% of revenue for the fiscal year ended  December  31,
1995. The $98,116 increase in general and administrative  expenses was primarily
attributable to an increase in professional expenses.

         Interest  Expense.  Net  Interest  expense  for the  fiscal  year ended
December  31,  1996 was $49,252 or 5% of revenue as compared to $24,655 or 2% of
revenue for the fiscal year ended  December 31, 1995.  Interest  expense for the
fiscal year ended  December  31,  1996 was  primarily  attributable  to interest
accrued on  subordinated  notes  issued by the  Company  and  factoring  charges
associated with receivables.

         Net Loss.  The Company  recorded a net loss of $192,588  for the fiscal
year ended  December  31, 1996 as  compared  to a net loss of  $223,457  for the
fiscal  year ended  December  31,  1995.  The  decrease  from in the net loss of
$30,869 was the result of lower operating  expenses  partially offset by reduced
revenues.

YEAR ENDED DECEMBER 31, 1995 COMPARED TO YEAR ENDED DECEMBER 31, 1994.

         Revenue.  Revenue  for the fiscal  year  ended  December  31,  1995 was
$1,097,550  as compared to  $1,342,212  for the fiscal year ended  December  31,
1994, a decrease of $244,658 or 19%.  Product revenues for the fiscal year ended
December 31, 1995 were  $397,550 as compared to  $1,342,212  for the fiscal year
ended  December 31,  1994,  a decrease of $944,662 or 71%.  Contract and license
revenue for the fiscal year ended  December 31, 1995 was $700,000 as compared to
$0 for the fiscal year ended  December  31, 1994,  an increase of $700,000.  The
decrease in product revenue was primarily  attributable to a discontinuation  of
the Company's printer and print server product lines.

         In 1995, the Company entered into  cooperative  development  agreements
with Analog Devices and Samsung  Electronics  Co. These  agreements  resulted in
contract and license revenues of $700,000.



                                       12





         Cost of Revenue. Cost of revenue for the fiscal year ended December 31,
1995 was  $496,866 or 45% of  revenue,  as  compared  to  $1,580,052  or 118% of
revenue for the fiscal year ended  December 31, 1994, a decrease of  $1,083,186.
Included  in the cost of revenue for fiscal  year 1994 are  inventory  and fixed
asset  write-offs of  approximately  $389,000,  and accelerated  amortization of
capitalized  software costs of approximately  $305,000 associated with the phase
out of the printer and print server product lines.

         Research  and  Development.  Research and  development  expense for the
fiscal year ended  December  31, 1995 was $331,279 or 30% of revenue as compared
to $398,026 or 30% of revenue for the fiscal year ended  December 31, 1994.  The
decrease of $66,747 was  primarily  attributable  to an increase in  development
work associated with the Company's agreement with Samsung Electronics,  with the
costs being charged to "Cost of Contract and License Revenue".

         Selling and  Marketing.  Selling and marketing  expenses for the fiscal
year ended  December  31,  1995 were  $117,896  or 11% or revenue as compared to
$794,873 or 59% of revenue for the year ended December 31, 1994. The decrease of
$676,977 was primarily attributable to the reduction in personnel to support the
sale and  promotion  of printers  and print  servers and  reduced  expenses  for
promotional activities.

         General and  Administrative.  General and administrative  expenses were
$358,040  or 33% of revenue  for the  fiscal  year ended  December  31,  1995 as
compared to $1,015,624 or 76% of revenue for the fiscal year ended  December 31,
1994. The $657,584 decrease in general and administrative expenses was primarily
attributable to a reduction in salaries and professional expenses.

         Interest  Expense.  Net  interest  expense  for the  fiscal  year ended
December 31, 1995 was $24,655 or 2% of revenue as compared to $199,134 or 15% of
revenue for the fiscal year ended  December 31, 1994.  Interest  expense for the
fiscal year ended  December  31,  1995 was  primarily  attributable  to interest
accrued on notes issued in connection with the Company's short-term financing.

         Net Loss.  The Company  recorded a net loss of $223,457  for the fiscal
year ended  December  31, 1995 as compared to a net loss of  $3,116,448  for the
fiscal  period  ended  December 31,  1994.  The  decrease in loss was  primarily
attributable  to  decreased  general   administration,   selling  and  marketing
expenditures.





LIQUIDITY AND CAPITAL RESOURCES

For the fiscal year ended December 31, 1996, the Company had a positive cashflow
from  operations  of $64,316.  This is primarily  attributable  to a decrease in
accounts  receivable.  At December  31,  



                                       13




1996 the Company  had current  assets of  $240,037  and current  liabilities  of
$713,724 and a working capital deficit of ($473,687).

         During 1995,  the Company  entered  into an agreement  with the Silicon
Valley Bank to borrow against receivables. The agreement calls for interest at a
monthly rate of 2.5% and requires an advance fee of 1%. As of December 31, 1996,
there were no outstanding loan amounts payable to Silicon Valley Bank.

         In May 31, 1996, the Company  commenced a limited  private  offering to
accredited  investors  of  subordinated   nonrecourse  promissory  notes  in  an
aggregate  principal  amount of up to  $500,000.  In  addition  to a note,  each
subscriber  received a five-year warrant to purchase two shares of the Company's
Common  Stock at an exercise  price of $.01 per share for each dollar  invested.
Principal  and interest  will be repaid,  if at all,  solely from the  Company's
pre-tax  earnings for each of the five fiscal years  commencing  with the fiscal
year ending  December 31, 1996.  Payments,  if any, will be made annually to the
holders of the notes within  thirty days after the Company files its Form 10-KSB
or its then  equivalent form with the Securities and Exchange  Commission.  Such
annual payments shall not exceed, in the aggregate, 25% of the Company's pre-tax
earnings, and shall not exceed over the five year term of the notes, three times
the principal  amount of the notes.  The offering closed on May 31, 1996 and the
Company  raised a total of  $283,688.  Included in this  amount were  $13,698 of
accrued  interest and $75,000 of  outstanding  debt that were converted into the
new promissory notes.

In Company has no current plans to raise  additional  capital in 1997. Funds for
development efforts will come from current or anticipated  licensing and royalty
fees.  If the  Company  is  unable  to fund its  operations  from  cash flow the
Company's  development  efforts  and  operations  will be  materially  adversely
effected.

CAPITAL EXPENDITURES

         The  Company  does  not  have  any  material  commitments  for  capital
expenditures at this time.


EFFECTS OF INFLATION

         The Company  believes  that the  relatively  moderate rate of inflation
over the past few years has not had a significant  impact on the Company's sales
or operating results.




INCOME TAXES

         The Company adopted Statement No. 109 "Accounting for Income Taxes," in
1993  and  its  implementation  has had no  effect  on the  Company's  financial
position and results of operation.



                                       14




ITEM 7. FINANCIAL STATEMENTS

         See Pages F-2 through F-19.



ITEM 8.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING
         AND FINANCIAL DISCLOSURE

     On January 24,  1996,  the Company  received  confirmation  from  Coopers &
Lybrand of the  decision by XLI that  Coopers & Lybrand  would not be engaged as
the Company's  independent  accountants.  The accounting firm of Wolf & Company,
P.C. was appointed  and approved by The Board of Directors to replace  Coopers &
Lybrand. There was no adverse opinion or a disclaimer of opinion or disagreement
on any matter of  accounting  principles  or  practices  in Coopers &  Lybrand's
report on the financial statements for either of the past two years.


ITEM 9    DIRECTOR'S EXECUTIVE OFFICERS, PROMOTERS AND CONTROL
          PERSONS; COMPLIANCE WITH SECTION 16(a) OF THE EXCHANGE ACT

     The current directors, executive officers and key employees of the Company,
their ages and their positions held in the Company are as follows:

Name                Age          Position

Anthony D'Amelio    67       President, Chief Executive Officer and
                             Chairman of the Board
James L. Salerno    66       Chief Financial Officer, Treasurer and
                             Secretary
Daniel J. Allen     36       Vice President of Research and
                             Development
Roger F. Salava     60       Director of Strategic and Business
                             Planning
Dr. Joseph L. Katz  54       Director and Vice President of Corporate
                             Planning
Vincent J. Spoto    51       Director

Dr. Adam Carley     56       Director

     Each  director  is elected  for a period of one year and  serves  until his
successor is duly elected by the stockholders. Officers are elected by and serve
at the discretion of the Board of Directors.

The  following is a summary of the  principal  occupations  during the past five
years of each of the  directors,  executive  officers  and key  employees  named
above:

     Anthony  D'Amelio,  67,  is a  founder  of the  Company  and has  served as
Chairman of the Board,  President and Chief  Executive  Officer since July 1994.
From March 1993 to July of 1994,  Mr.  D'Amelio  served as a  



                                       15




consultant  to the Company and from June 1989 to March 1993,  Mr.  D'Amelio  was
Treasurer,  Chief Financial Officer, and Director of the Company. From July 1988
to July  1990,  Mr.  D'Amelio  served a senior  consultant  to Alcan  Corp.,  an
aluminum and chemicals  producer in the areas of business  development and joint
ventures.  Previously, Mr. D'Amelio was Vice President,  Computer Operations for
Honeywell, Inc. and held several executive positions at General Electric and Cie
Bull.

         James L. Salerno, 66, Chief Financial Officer,  Treasurer and Secretary
since March 1995. From 1991-1995 Mr. Salerno was Treasurer of Jem International.
He is a former V.P. of Finance at Preview  Products Inc. from 1972-1991 and V.P.
Group  Controller at AMF Inc. from  1952-1972.  Mr. Salerno  graduated from Pace
University  with a BBA  degree and holds a Master of  Science  degree  from Long
Island University and Harvard Business School.

         Daniel Allen, 36, Vice President of Research and Development. Mr. Allen
joined the Company in May 1991.  Prior to joining  the  Company,  Mr.  Allen was
Chief  Engineer  at Cirrus  Technology,  Inc.,  responsible  for the  design and
manufacturing  of high resolution color laser film recorders and Senior Engineer
at Analogic  Corp. Mr. Allen  graduated  from Penn State  University and holds a
B.S. degree in Mathematics with a minor in Computer Science.

         Roger  Salava,  60, was  appointed  Director of Strategic  and Business
Planning  in  August  1994.  Mr.  Salava  joined  XLI in 1991 as Vice  President
Engineering.  Prior to joining  XLI,  Mr.  Salava was Senior Vice  President  of
Kodak/EPPS,  a subsidiary of Eastman Kodak Corporation and former Vice President
of Engineering for  AGFA/Compugraphic  Corporation.  He holds a B.S. degree from
Marquette  University  and  an  M.S.  from  Northwestern  University,   both  in
Electrical Engineering.

         Joseph  L.  Katz,   54,  was  appointed   Vice   President,   Corporate
Development,  November  1996 and has been a Director  since  September 30, 1996.
From 1977 to 1996 Dr. Katz has held the  positions of Group  Leader,  Department
Head, Senior Principal Engineer of Network and Systems Management at Mitre Corp.
Dr. Katz holds Ph.D.  and M.S.  degrees in  Electrical  Engineering  from Purdue
University.

         Vincent J. Spoto,  51, a founder of the Company;  previously  served as
President,  Chief Executive  Officer and Chairman of the Board of Directors from
June 1989 to November  10, 1993.  Mr. Spoto was a consultant  to the Company for
November 1994 to 1996. Presently,  Mr. Spoto is President of ImageLabs,  Inc. On
January  6,  1997,  Mr.  Spoto was  appointed  to fill a vacancy on the Board of
Directors.  Mr. Spoto holds an Associates Degree in Electrical  Engineering from
the Wentworth Institute of Technology.

         Adam Carley, 56, Chief Scientist,  Director and founder of the Company.
Dr. Carley invented the laser printing  technology that forms the basis of XLI's
imaging enhancement  technology.  For the past five years, Dr. Carley has been a
consultant  to the Company and President of Carley  Corporation,  a developer of
advanced electronic circuitry for high quality laser image printing.  Dr. Carley
received his Ph.D. 



                                       16




in Electrical Engineering from the Massachusetts Institute of Technology.

   The members of the Board of  Directors  do not receive any cash  compensation
for their services as Directors.


ITEM 10 EXECUTIVE COMPENSATION

         The  following  table  sets  forth  all cash  compensation  paid by the
Company to its Chief Executive  Officer.  No executive  officer  received annual
salary and bonus exceeding  $100,000 for their services in all capacities to the
Company during the fiscal year ending December 31, 1996.






<TABLE>
<CAPTION>

                          SUMMARY COMPENSATION TABLE

                                                    Long-Term Compensation
               Annual Compensation                   Awards         Payouts

                                        Other    Restricted
                                        Annual     Stock             LTIP     All Other
Name and     Year   Salary    Bonus  Compensation  Awards   Options Payouts  Compensation  Principal
<S>          <C>      <C>      <C>       <C>        <C>       <C>     <C>         <C>         <C>
Position              ($)      ($)       ($)        ($)       (#)     ($)         ($)
  (a)        (b)      (c)      (d)       (e)        (f)       (g)     (h)         (i)


Anthony D.   1996    $22,367    --       --      $2,000 (a)
D'Amelio     1995    $27,875                     $3,750 (b)  80,000
President,                                       $1,562 (c)
Executive    1994    $35,000                                 50,000
Officer and Chairman of the Board

(a) 200,000 Shares of Common Stock
(b) 120,000 Shares of Common Stock
(c)  50,000 Warrants

During  1995  investors  who loaned  money to the Company  received  warrants (3
warrants for each $1 loaned). Mr. D'Amelio received 88,000 warrants.

</TABLE>





ITEM 11  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

         The following  table sets forth, as of March 12, 1997, the ownership of
the Company's Common Stock by (i) each person who is 



                                       17




known by the Company to own of record or beneficially  more than five percent of
the Company's Common Stock,  (ii) each of the Company's  directors and (iii) all
directors,  and  officers  as  a  group.  Except  as  otherwise  indicated,  the
stockholders  listed in the table have sole  voting and  investment  powers with
respect to the shares  indicated.  As of March 11, 1997, the Corporation had 225
Stockholders of record.



          Name and Address of       Number of Shares of   Percentage
           Beneficial Owner         Common Stock          Class(1) (2) (3)
                                    Beneficially Owned     of


Anthony D. D'Amelio ............     546,221*             28.2%
  101 Billerica Ave.
  5 Billerica Park
  N. Billerica, Massachusetts 01862

Roger Salava.....................    134,157               7.5%
  101 Billerica Ave.
  5 Billerica Park
  N. Billerica, Massachusetts 01862

James L. Salerno.................    138,584               7.7%
  101 Billerica Ave.
  5 Billerica Park
  N. Billerica, Massachusetts 01862

Daniel Allen ....................    105,000               5.8%
  101 Billerica Ave.
  5 Billerica Park
  N. Billerica, Massachusetts 01862

Joseph Katz .....................    186,422               9.6%
  101 Billerica Ave.
  5 Billerica Park
  N. Billerica, Massachusetts 01862

Vincent Spoto....................     81,883               4.7%
  50 Cypress Road
  Wellesley, MA  02181

Adam Carley......................    104,917               5.8%
  6 Hillside Rd.
  Windham, NH  03087

All Directors,
  and Officers as a group
  (7 persons)....................    849,605              47.8%

  *Does  not  include  5,000  shares of Series A  Preferred  Stock  owned by Mr.
D'Amelio. No other director or officer owns directly or indirectly any shares of
the Company's Series A Preferred Stock.



                                       18



(1)Pursuant to the rules of the Securities  and Exchange  Commission,  shares of
Common Stock which an individual or group has a right to acquire  within 60 days
pursuant to the exercise of options or warrants are deemed to be outstanding for
the purpose of computing the percentage  ownership of such  individual or group,
but are  not  deemed  to be,  outstanding  for  the  purpose  of  computing  the
percentage ownership of any other person shown in the table. (2)Does not include
(i) 70,147 shares  issuable  upon  exercise of a warrant  issued to Thomas James
Associates,  Inc. in connection with the Company's initial public offering which
was completed in January 1993; and (ii) 701,468 shares issuable upon exercise of
the warrants  included on the units sold to the public as part of the  Company's
initial  public  offering in January  1993.  (3) Does not include  36,298 shares
issuable upon exercise of a warrant issued to Thomas James  Associates,  Inc. in
connection with the Company's  offering of Series A Preferred Shares in February
1994; and 362,984 shares issuable upon exercise of the warrants  included in the
offering in February 1994.

At December 31, 1996 the Company had reserved 3,099,607 shares of Common Stock.
(For breakdown see page F-17)

ITEM 12. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS


      In January  1990,  the Company  entered  into an  Agreement  (the  "Carley
Agreement')  with the  Carley  Corporation  ("Carley  Corporation"),  a  company
founded by Dr.  Adam L.  Carley,  a  co-founder  of XLI,  pursuant  to which the
Company  acquired an  exclusive  worldwide  license to certain  technology  (the
"Carley Technology") for the printing of text, graphics and photographic images.
In consideration  therefor, the Company issued 268,040 shares of Common Stock to
the two  stockholders of Carley  Corporation,  Dr. Adam L. Carley and Leonard R.
Weisberg (also a co-founder of the Company),  and agreed to pay royalties  equal
to 5% of  monetary  receipts  resulting  from  the  sale by XLI of  hardware  or
software  products  or  services  based  upon  or  associated  with  the  Carley
Technology  and 33  1/3% of  monetary  receipts  from  sublicensing  the  Carley
Technology to XLI. All royalty  payments  terminate upon payment of a cumulative
total of $2.4 million, at which time the Carley Corporation has agreed to assign
to the  Company  all  rights,  title  and  interest  to the  Carley  Technology,
including any improvements to the Carley Technology or future developments based
on the Carley  Technology.  The  Company has  sublicensed  on an  exclusive  and
royalty-free  basis the Carley  Technology to the Carley  Corporation for retail
services  including  but not limited to stores,  kiosks and booths for  purposes
including but not limited to picture making and picture reproduction.

     In December  1993,  the Company and Carley  Corporation  amended the Carley
Agreement such that Carley  Corporation was to be paid minimum  royalties of (i)
$75,000 in fiscal year 1994; (ii) $82,500 in fiscal year 1995; and (iii) $90,000
in fiscal year 1996.  Additionally,  if Carley  Corporation  develops new Carley
Technology and such new Carley  Technology were sublicensed by XLI and the total
sublicense fees received by XLI for such new Carley Technology exceeded $400,000
during the period from 1994 through 1996  (hereinafter  called  "excess  



                                       19




fees"),  then XLI would pay Carley  Corporation  25% of the excess fees.  In the
event that XLI had a net loss before taxes and interest but after the receipt of
such total  sublicense  fees during the six month period ended in the month when
any excess fee payment was due,  then no excess fee payment would be made by XLI
for that month and XLI would have no future  obligation  to pay that  excess fee
payment.  Based on the results for the period 1994 to 1996,  no excess fees were
payable to the Carley Corporation.

        Effective January 1, 1997, the Company and the Carley  Corporation again
amended the Carley  Agreement such that the Company will pay a royalty of 15% of
cash  receipts  generated  from  sales  or  licenses  incorporating  the  Carley
Technology  up to a cumulative  total of $2.4  million,  in lieu of the previous
royalty  rate of 5% on sales of hardware  and  software  products and 33 1/3% of
license fees.




EMPLOYMENT AGREEMENTS


         Effective  as  of  December  30,  1993,  the  Company  entered  into  a
consulting agreement (the Spoto Consulting Agreement) with Vincent J. Spoto, the
Company's  former President and Chief Executive  Officer.  Pursuant to the Spoto
Consulting  Agreement,  Mr. Spoto serves as a consultant to the Company's  Chief
Executive  Officer and Board of Directors at a consulting  fee of $3,958.33  per
month  through  May  31,  1997.  The  Spoto  Consulting   Agreement  includes  a
non-competition  provision which prevents Mr. Spoto from directly competing with
the  Company  during  the term of the  Spoto  Consulting  Agreement.  The  Spoto
Consulting Agreement also includes  confidentiality  provisions and provides for
the  assignment  by Mr.  Spoto of any  inventions  or  technology  conceived  or
developed by Mr. Spoto during the period of the Spoto Consulting Agreement which
result from or are  suggested by any task  assigned to or performed by Mr. Spoto
as a consultant to the Company.

     On February 1, 1994, the Company  entered into a Consulting  Agreement (the
Salava  Consulting  Agreement)  with  Roger  Salava.   Pursuant  to  the  Salava
Consulting  Agreement,  Mr. Salava  currently  serves as Director of Strategic &
Business Planning at the rate of $3,750 per month through November 30, 1997. The
Salava Consulting  Agreement includes  non-competition  provisions which prevent
Mr.  Salava  from  competing  with the  Company  during  the term of the  Salava
Consulting  Agreement  and for six  months  thereafter.  The  Salava  Consulting
Agreement also includes  confidentiality  provisions and requires the assignment
by Mr.  Salava to the  Company of any  inventions  or  technology  conceived  or
developed by Mr.  Salava  during the period of the Salava  Consulting  Agreement
which relate to the business of the Company.




                                       20




ITEM 13 EXHIBITS AND REPORTS ON FORM 8-K

      (a) Exhibits.  The following  exhibits  required to be filed  herewith are
incorporated by reference to the filings previously made by the Company as noted
below (the number before each Exhibit  indicates the number of the Exhibit as it
was filed in the document referenced below):

<TABLE>
<CAPTION>

Exhibit Number                 Title
<S>                             <C>
1.1**                          Underwriting Agreement

1.2**                          Agreement Among Underwriters

3.1*                           Restated Certificate of Incorporation, as amended

3.2*                           By-laws of the Registrant

4.1**                          Certificate of Designations, Preferences and Rights of Series A Cumulative
                               Redeemable Convertible Preferred Stock

4.2**                          Specimen Series A Preferred Stock Certificate

4.3**                          Specimen Common Stock Purchase Warrant

4.4**                          Form of Warrant Agreement

4.5**                          Form of Warrant to be issued to the Representative

10.9*                          Equipment Lease Agreement between the Company and Alco Capital Resources, Inc.
                               dated February 26, 1992

10.11*                         Agreement between the Company and William T. Lundberg, d.b.a. Alliance Associates
                               dated February 11, 1992

10.12*                         Form of Stock Escrow Agreement among American Stock Transfer & Trust Company, the
                               Company and the stockholders of the Company

10.13*                         1990 Stock Option Plan

10.14*                         1992 Stock Option Plan

10.15*                         Form of Financial Consulting Agreement between the Company and the Underwriter

10.16*                         Form of Investment Banking Agreement between the Company and the Underwriter

10.17*                         Research and Development Agreement between the Company and Kroy, Inc. dated October
                               26, 1990, as amended

10.18*                         Form of Employee Development and Confidential 



                                       21




                               Information Agreement

10.19*                         Agreement between the Company, Carley Corporation and Informed Decisions dated
                               January 15, 1990, as amended

10.19.A                        Fifth Amendment Agreement between the Company, Carley Corporation dated February
                               12, 1997. (Filed with Form 10-KSB December 31, 1996)

10.26**                        Second Amendment Agreement dated December 16, 1993 between the Company and Carley
                               Corporation

10.28**                        Agreement between the Company and TOP Alliance Consultants dated July 5, 1993

10.29**                        Form of Merger and Acquisition Agreement

10.32**                        Consulting Agreement between the Company and Roger Salava dated February 1, 1994

10.33**                        Consulting Agreement between the Company and Vincent J. Spoto effective as of
                               December 30, 1993



10.37                          Agreement between the Company and Analog Devices, Inc. dated February 22, 1995

10.39                          Development and Licensing Agreement dated April 26, 1995, between the Company and
                               Samsung Electronics, Ltd. (filed with September 30, 1995 Form 10-QSB)

10.40                          Lease for premises at 101 Billerica Ave.,  N. Billerica, MA dated June 6, 1995
                               (filed with September 30, 1995 Form 10-QSB)

10.41                          License and Royalty Agreement dated March 11, 1996, between the Company and
                               Pipeline Associate, Inc.
                               (filed with March 30, 1996 Form 10-QSB)

10.42                          License and Royalty Agreement dated November 13,
                               1996 between the Company and Xionics Document
                               Technologies, Inc. (filed on November 14, 1996)

</TABLE>



                                       22



*     Filed with the Commission on June 18, 1992; Registration Statement    
       No. 33-48684.
**    Filed with the Commission on August 31, 1992; Registration Statement 
       No. 33-48684.


         (b) Reports on Form 8-K. The Company has filed the following reports on
Form 8-K during the three months ended December 31, 1996.

         1 - November 14, 1996

         The  Company  and  Xionics  Document  Technologies  Inc.  announced  on
November 14, 1996 that the companies  signed a Memorandum of  Understanding  for
Xionics to acquire XLI.  Simultaneously the companies announced that Xionics has
acquired a non-exclusive license to all XLI printing technology.

         2 - November 14, 1996

         A Licensing  and  Royalty  Agreement  was  entered  into by and between
Xerographic Laser Images Corp. and Xionics Document Technologies, Inc.

         3 - December 12, 1996

         Xionics  Document   Technologies  Inc.  and  Xerographic  Laser  Images
Corporation  announced on December 12, 1996 that the  companies  had  terminated
their Memorandum of Understanding for Xionics to acquire XLI.



Exhibit 10.19.A


                            Fifth Agreement Amendment


This amends the Agreement dated 15 January 1990 (hereinafter  referred to as the
"Printer  Agreement")  among  Carley  Corporation  (hereinafter  referred  to as
"Carley"),  Xerographic  Laser Images  Corporation  (hereinafter  referred to as
"XLI"),and Informed Decisions,  and all amendments prior to this Fifth Agreement
Amendment  (hereinafter referred to as "Amendment") as applicable thereto. It is
noted that the Third  Amendment to the Carley  Agreement  has been null and void
because the proposed merger with Jardine Cho, Ltd. was not completed.

WHEREAS, XLI expects it royalty ( including license fee) income from the sale of
sublicenses to increase over the next few years,  and  accordingly XLI wishes to
increase  its  profits  over the next few years or more by having its  resulting
royalty payments to Carley for the sale of sublicenses substantially reduced;

WHEREAS,  to reduce  the  possibility  of  future  disputes  concerning  royalty
payments  to Carley and  thereby  promote  potential  team work



                                       23



between  XLI  and  Carley,   XLI  wishes  to  simplify  the   determination  and
administration of the royalty payments due to Carley;

WHEREAS,  Carley has  completely  and  successfully  fulfilled  the  obligations
indicated to the Printer  Agreement,  and has performed  very  considerable  and
important work for XLI's benefit beyond the scope of the Printer Agreement,  and
XLI is very  satisfied with and highly values these  contributions  by Carley to
XLI;

WHEREAS,  Carley wishes to help XLI achieve improved  profitability by accepting
substantially  lower  royalty  payments  for XLI's sale of  sublicenses,  and is
willing to have the determination and  administration of the royalty payments by
XLI to Carley simplified; and

WHEREAS,  both XLI and  Carley  wish to  further  clarify  certain  items in the
Printer  Agreement and add certain items which were not addressed in the Printer
Agreement;

NOW,  THEREFORE,  the parties  hereto agree to the  following  amendments to the
Printer Agreement which will be effective as of January 1, 1997:

1.  Definitions:  Section A. 1. of the Printer  Agreement is hereby canceled and
    replaced by: "Carley  Technology"  means both hardware and software  methods
    and implementations,  manufacturing  methods and  implementations,  designs,
    techniques, and inventions whether patentable or not, originated, developed,
    and/or  significantly  contributed  to by  Carley,  comprising  information,
    documents,  samples, models, equipment,  source codes, electronically stored
    information,  and  know-how  relating  to,  connected  with,  or in any  way
    describing the electronic  printing (including plate making) of pictures and
    text,  including  both  black-and-white  and color pictures and text, to the
    extent to which they are used or can be used for printing  applications such
    as laser printers, ink jet printers,  fax, and multifunction.  It also means
    embodiments of and changes and improvements to Carley  Technology  developed
    by  XLI  and  new  concepts  originated  by  XLI  which  incorporate  Carley
    Technology,   including   applications  of  Carley  Technology  to  specific
    combinations  of computers  and  electronic  printers,  and  including  both
    hardware and software. There is no claim or guarantee that Carley Technology
    in aggregate or in part thereof is not public  information,  or that patents
    resulting from Carley Technology will be held to be valid, or that products,
    licenses,  or sublicenses sold by XLI  incorporating  Carley Technology will
    not be held to infringe other patents.  "Carley Technology" will hereinafter
    in this  amendment be referred to as "Carley  Printer  Technology."  "Carley
    Non-Printer  Technology" means technologies  originated,  developed,  and/or
    implemented  by  Carley  which  are  used  or  can be  used  for  all  other
    applications  such as  displays  and  communication  devices  ("non-printing
    applications"). Other technologies originated, developed, and/or implemented
    by XLI not  incorporating  Carley Printer  Technology,  independent of their
    application,  are the property of XLI ("XLI  Technology").  It is noted here
    for clarity that XLI has not been granted  rights of  privileges of any sort
    to use Carley Printer Technology for non-printing applications.




                                       24




         1.1 There is no  obligation,  implication,  or  presumption of any sort
         that  Carley  will  make  further   contributions   to  Carley  Printer
         Technology;  such contributions shall be made at the sole discretion of
         Carley.

2.  Cancellations:  Sections F.1., F.2., F.3., and F.5. of the Printer Agreement
    are canceled in there entirety.

3.  Royalty Basis:  Royalties  payable by XLI to Carley will be based on the Net
    Cash Receipts,  which shall mean cash (or cash equivalents)  received by XLI
    after  December 31, 1996,  from  customers,  licensees and  sublicensees  in
    consideration  for items  including but not limited to hardware and software
    products, services, and licenses or sublicenses, and independent of the date
    of the  agreement  or  contract  granting  said  licenses  and  sublicenses,
    provided said items at least partially incorporate Carley Printer Technology
    as defined  heretofore,  less any refunds made by XLI of such cash receipts,
    and less import and export duties and import and export taxes  allocable to,
    and not  exceeding,  such cash receipts when paid by XLI under  contracts or
    agreements with third parties for products sold, rights granted,  and/or for
    services  performed  by XLI if and only if the  payment  of said  duties and
    taxes decrease profits.

         3.1.     If in any given month the Net Cash Receipts are negative,  the
                  negative amount will be carried forward to future months until
                  eliminated.

4.  Royalty  Payments:  Royalties  payable  by XLI to Carley  shall be paid on a
    monthly basis and determined by multiplying the monthly Net Cash Receipts by
    15%. Such royalty payments shall be made for each month during the last week
    of the subsequent month at the latest.

         4.1.     As stated in the Second Agreement Amendment:  Royalty payments
                  from XLI to  Carley  shall  cease  when an  accumulated  total
                  royalty fee of $2.4 million has been paid to Carley. The total
                  royalty  fee of  $2.4  million  shall  be  considered  a first
                  priority fiduciary responsibility of XLI.

5.  Royalties in Arrears Due Carley:  As of December  31, 1996,  XLI owes Carley
    accrued  royalties of $103,375 (based on currently  available  information).
    Commencing in January 1997, XLI agrees to pay Carley $7,500 per month during
    the last week of each calendar  month until such accrued  royalties are paid
    in full. It is noted that Section F.10.d. of the Second Agreement  Amendment
    may increase the accrued royalties that XLI owes Carley.

6.  Holding of Royalties: The portion of the Net Cash Receipts that are required
    to be paid to  Carley  as  royalties  according  to  Section 4 above and the
    amount  required to be paid to Carley  according to Section 5 above shall be
    deemed bay all  parties  to be the  property  of Carley the moment  they are
    received by XLI and held by XLI




                                       25




    accordingly.

7.  Interest:  In the event that XLI fails to pay when due the  monthly  royalty
    payments  called by Section 4 hereof  and/or  the  monthly  $7,500  payments
    called for by Section 5 hereof, then such unpaid amounts shall bear interest
    at the rate of 10% per annum compounded continuously until paid in full.

8.  Security  Interest:  When the aggregated  monthly royalty payments by XLI to
    Carley  pursuant  to  Sections 4 and 5 above total  %200,000,  Section  F.9.
    (Security  Interest)  of the  Printer  Agreement  will  be  canceled  in its
    entirety and Carley will withdraw the UCC-1 registration.

9.  Carley  Work on  Behalf  of XLI:  Carley  and XLI  agree  that  any  work on
    technology done by Carley exclusive of Carley Printer Technology will not be
    deemed  to be done on  behalf  of XLI  unless  and  except  under  terms and
    conditions mutually agreed in writing between XLI and Carley. Further, it is
    understood  that  technology  done by Carley may involve both Carley Printer
    Technology and Carley Non- Printer  Technology;  any such Carley Non-Printer
    Technology done by Carley will not be considered to be done on behalf of XLI
    unless and except under terms and conditions  mutually  agreed to in writing
    between XLI and Carley.

10. Multi-Technology  Patents: In the event that technology includes both Carley
    Printer Technology and Carley Non-Printer Technology and patents are applied
    for for such  technology,  then XLI and Carley shall jointly own such patent
    applications  and the  resulting  patent(s) if granted,  XLI and Carley will
    jointly notify the patent office of the joint  ownership,  and the following
    provisions will then apply:

         10.1.     XLI will have the exclusive  right to sell products  based on
                   and to license third parties  exclusively or  non-exclusively
                   or sell its interest (with the buyer subject this  Amendment)
                   in such  patent  applications  and patents ( if and when they
                   are issued) for and only for  printing  applications.  Carley
                   will have the exclusive  right to sell products  based on and
                   to license third parties  exclusively or  non-exclusively  or
                   sell its interest (with the buyer subject to this  Amendment)
                   in such patent applications and patents (if and when they are
                   issued) for and only for non- printing applications.

         10.2.     If the patent  application is initiated by XLI, XLI will have
                   the  responsibility  to  pursue  the  issuance  of such  U.S.
                   patents,  and  thereafter  to track the need for  payment  of
                   maintenance fees for both patent  applications.  XLI will pay
                   all U.S.  Patent  Office  fees  involved in having the patent
                   issued  and  maintained,  and will be  reimbursed  by  Carley
                   within  30 days of  notification  at the  rate of 50% of such
                   fees  based  on  the  small  entity  basis.   If  the  patent



                                       26




                   application  is  initiated  by Carley,  Carley  will have the
                   responsibility  to pursue the issuance of such U.S,  patents,
                   and thereafter to track the payment for maintenance  fees for
                   both patent  applications.  Carley  will pay all U.S.  Patent
                   Office  fees   involved  in  having  the  patent  issued  and
                   maintained,  and will be  reimbursed by XLI within 30 days of
                   notification  for those fees,  less 50% of such fees based on
                   the small entity basis.

         10.3.     XLI and Carley  will work  together in  responding  to patent
                   office  actions,  including  utilization of conference  calls
                   with the patent  examiner for substantive  issues.  Both must
                   agree to responses,  striving for the broadest coverage. If a
                   patent  application is split, such resulting patents would be
                   jointly  owned  under  the  terms  of this  Amendment  unless
                   applicable to one field only.

         10.4.     Either  party may employ legal  counsel or conduct  patent or
                   prior art searches at their own expense.  Such expense can be
                   incurred  on a shared  basis only by written  consent of both
                   parties.

         10.5.     Either  party may apply for  foreign  patents  at their  sole
                   discretion  and their sole expense.  In such case,  the party
                   will  immediately  notify the other party of such  actions in
                   writing.  Such patents will be  considered  jointly owned for
                   the purpose of Sections 10.1.,  10.4.,  10.6.,  10.7., 10.8.,
                   and 10.9. hereof.

         10.6.     If either  party  wishes to abandon its  interest in a patent
                   application  or  patent  after  it is  issued  (such  as when
                   maintenance fees become due), it will immediately  inform the
                   other  party,  and  relinquish  its  ownership  in the patent
                   application  and rights  under 10.3.  and 10.8.  to the other
                   party if the other party wishes to continue it.

         10.7.     In the event that patent  litigation  and/or an injunction is
                   brought  against XLI and/or Carley  concerning the sale, use,
                   or  manufacturing  of hardware or  software  products  and/or
                   licensing or sublicensing  by XLI and/or Carley,  then (a) if
                   pertaining  to  applications  XLI will  hold  Carley  and its
                   principals  blameless and harmless and not hold Carley or its
                   principals responsible for any of XLI's expenses involved, or
                   (b) if pertaining to non-printing applications but associated
                   with  patents  jointly  owned by Carley and XLI,  Carley will
                   hold XLI and its  principals  blameless and harmless and will
                   not  hold  XLI  or  its  principals  responsible  for  any of
                   Carley's expenses involved.

         10.8.     Either  party  at its  own  choice  and  expense  may  pursue
                   infringers  in and only in its field and  collect  associated
                   damages.  If an infringer is infringering in both the printer
                   and non-printer fields, then such pursuit may be 




                                       27




                   done jointly by written agreement,  and any damages collected
                   will  be  divided  proportionally   according  to  reasonable
                   applicability.  In the  event  that  either  party  initiates
                   infringement  litigation or formal  notification to suspected
                   infringer,  that  party  will  immediately  inform  the other
                   party.

11. Other Terms

         11.1.     Royalty payments according to Sections 4 and 5 above shall be
                   deposited  to Bank  Boston to account  #2651 408 8 (under the
                   name of Adam L.  Carley  and  Leonard  R.  Weisberg)  for the
                   benefit of Carley unless otherwise directed by Carley.

         11.2.     XLI will provide an unaudited  report to Carley within thirty
                   days subsequent to the end of each month and calendar quarter
                   providing the total XLI cash receipts, the Net Cash Receipts,
                   the  exclusions  according to Section 3 above,  and the basis
                   for such  exclusions.  XLI will also provide Carley according
                   to the same  schedule  a  record  of the  total  new and back
                   royalty  payments  to Carley  according  to  Sections 4 and 5
                   above respectively.  XLI will further provide Carley with the
                   results of its annual  financial  audit includes the Net Cash
                   Receipts  and  royalty  payments  to Carley,  but no separate
                   auditor's  report will be required for such Net Cash Receipts
                   and royalty payments to Carley.

         11.3.     Adam L.  Carley  may  attend  XLI  meetings  and  appropriate
                   customer  meetings.  XLI  will  provide  Adam L.  Carley  and
                   Leonard R. Weisburg ( the Carley shareholders) full access to
                   XLI  records  including  but not  limited to  reports,  Board
                   Minutes,  contracts,  and financial  data. Adam L. Carley and
                   Leonard  R.  Weisburg  agree  to  keep  all  XLI  proprietary
                   information confidential,  and shall not disclose or use such
                   information without the prior written consent of XLI.

         11.4.     The invalidity or  unenforceability  of any provision of this
                   Amendment will not affect the validity or  enforceability  of
                   any other provision and any  unenforceable  provision will be
                   deemed severable from and shall not render  unenforceable the
                   remainder of this Amendment.

         11.5.     Waivers:  No waiver of any right hereunder by any party shall
                   operate as a waiver of any other right,  or of the same right
                   with respect to any subsequent occasion for its exercise,  or
                   of any right to damages. No waiver by any party of any breach
                   of this Amendment shall be held to constitute a waiver of any
                   other breach or a continuation of the same breach.


         11.6.     Other Agreements:  This Amendment,  and the Printer Amendment




                                       28



                   as amended,  contain the entire understanding of the parties,
                   written or oral, with respect to the subject matter hereof.

         11.7.     Counterparts: This Amendment may be executed in counterparts,
                   each of  which  together  shall  constitute  one and the same
                   instrument.

         11.8.     Amendment:  This Amendment can be amended only in writing and
                   with the mutual  consent and agreement by both Carley and XLI
                   and signed by the duly authorized officers of the parties.

         11.9.     Disputes: In the event of any disputes between XLI and Carley
                   and/or  their  principals  and  agents  regarding  any matter
                   governed by this  Amendment or any other matter,  the parties
                   will,  if they  cannon  resolve  the  matter by  negotiation,
                   submit the dispute to  mediation/arbitration.  The provisions
                   of Schedule "A" attached to the Printer  Agreement will apply
                   to any mediation/arbitration.

IN WITNESS WHEREOF THE PARTIES HAVE EXECUTED THIS AMENDMENT  EFFECTIVE AS OF THE
DATE SET FORTH ABOVE.

XLI CORPORATION:

     By /s/ Anthony D. D'Amelio                    2/12/97
                                                   Date signed

CARLEY CORPORATION

         By /s/ Adam L. Carley                     2/12/97
                                                   Date signed

         By /s/ Adam L. Carley                     2/12/97
                                                   Date signed

         By /s/ Leonard R. Weisburg                2/11/97
                                                   Date signed




                                       29




                                   SIGNATURES



         Pursuant to the  requirements  of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant certifies that it has duly caused this Form
10-KSB to be signed on its behalf by the undersigned, thereunto duly authorized,
on March 7, 1997.

                      XEROGRAPHIC LASER IMAGES CORPORATION


                                                   By: /s/ Anthony D. D'Amelio



         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
this Report has been signed by the following  persons in the  capacities  and on
the dates indicated.

       Name                        Capacity                          Date


                              President, Chief Executive         March 7, 1997
/s/ Anthony D. D'Amelio       Officer and Chairman
                              of the Board (Principal
                              Executive Officer)

                              Chief Financial Officer,
/s/ James L. Salerno          Treasurer, Secretary               March 7, 1997
                              (Principal Financial Officer)


/s/ Dr. Joseph Katz           Director                           March 7, 1997




/s/ Vincent J. Spoto          Director                           March 13, 1997





/s/ Dr. Adam L. Carley        Director                           March 7, 1997











                                                   






                      Xerographic Laser Images Corporation
                          Index to Financial Statements





                                                            Page(s)

Independent Auditor's Report                                 F-2
                                                             F-2b

Balance Sheets as of December 31, 1996 and 1995              F-3

Statements of Operations for the years
  ended December 31, 1996, 1995 and 1994                     F-4

Statements of Changes in Stockholders'
  (Deficit) Equity for the years ended
  December 31, 1996, 1995, and 1994                          F-5

Statements of Cash Flows for the years
  ended December 31, 1996, 1995 and 1994                     F-6

Notes to Financial Statements                            F-7 to F-19




                                       F-1


                      [LETTERHEAD OF WOLF & COMPANY, P.C.]


REPORT OF INDEPENDENT ACCOUNTANTS

To the Board of Directors and Stockholders of

 Xerographic Laser Images Corporation:

We have audited the  accompanying  balance  sheets of  Xerographic  Laser Images
Corporation as of December 31, 1996 and 1995 and the related statements of loss,
stockholders'  deficit  and cash  flows  for  each of the  years in the two year
period then ended.  These  financial  statements are the  responsibility  of the
Company's  management.  Our  responsibility  is to  express  an opinion on these
financial statements based on our audit. The financial statements of Xerographic
Laser Images  Corporation  for the year ended  December 31, 1994 were audited by
other  auditors  whose  report  dated  April 12, 1995  included  an  explanatory
paragraph that described the uncertainty of the Company's ability to continue as
a going concern.

We  conducted  our  audits  in  accordance  with  generally   accepted  auditing
standards.  Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.

In our opinion,  the financial  statements  referred to above present fairly, in
all  material  respects,  the  financial  position of  Xerographic  Laser Images
Corporation as of December 31, 1996 and 1995 and the results of their operations
and cash flows for the years ended  December  31, 1996 and 1995,  in  conformity
with generally accepted accounting principles.

The  accompanying  financial  statements  have been  prepared  assuming that the
Company  will  continue  as a  going  concern.  As  discussed  in  Note 1 to the
Financial Statements,  the Company has suffered recurring losses from operations
and has a net capital  deficiency that raise substantial doubt about its ability
to continue as a going  concern.  Management's  plans in regard to these matters
are also  discussed  in Note 1. The  financial  statements  do not  include  any
adjustments that might result from the outcome of this uncertainty.

January 17, 1997,                        Wolf & Company, P.C.
except for Note 9, as to which
the date is February 12, 1997
Boston, Massachusetts



                                      F-2



                    [LETTERHEAD OF COOPERS & LYBRAND L.L.P.]


                       REPORT OF INDEPENDENT ACCOUNTANTS

To the Chairman of the Board and Stockholders of

 Xerographic Laser Images Corporation:

We have  audited the  accompanying  balance  sheet of  Xerographic  Laser Images
Corporation as of December 31, 1994,  and the related  statements of operations,
cash flows and  stockholders'  deficit for the year then ended.  These financial
statements   are  the   responsibility   of  the   Company's   management.   Our
responsibility  is to express an opinion on these financial  statements based on
our audits.

We  conducted  our  audits  in  accordance  with  generally   accepted  auditing
standards.  Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.

In our opinion,  the financial  statements  referred to above present fairly, in
all  material  respects,  the  financial  position of  Xerographic  Laser Images
Corporation as of December 31, 1994,  and the related  statements of operations,
cash flows and stockholders'  deficit for the year then ended in conformity with
generally accepted accounting principles.

The  accompanying  financial  statements  have been  prepared  assuming that the
Company  will  continue  as a  going  concern.  As  discussed  in  Note 1 to the
Financial Statements,  the Company has suffered recurring losses from operations
and has a net capital  deficiency that raise substantial doubt about its ability
to continue as a going  concern.  Management's  plans in regard to these matters
are also  discussed  in Note 1. The  financial  statements  do not  include  any
adjustments that might result from the outcome of this uncertainty.

                                           Coopers & Lybrand L.L.P.


Boston, Massachusetts
April 12, 1995



                                      F-2b


<TABLE>
<CAPTION>
 
                      XEROGRAPHIC LASER IMAGES CORPORATION
                                 Balance Sheets

                                                                                     December 31,                December 31,
                                                                                         1996                        1995
                                                                                    --------------             ----------------
<S>                                                                                      <C>                         <C> 

                                  ASSETS
                              ===============
Current assets:                                                                                                 
   Cash                                                                            $      219,723             $              -
   Accounts receivable, less allowance for                                                                      
      doubtful accounts of $5,000 in 1996 and
      $14,033 in 1995                                                                      20,314                      279,271
   Finished goods inventory                                                                     -                       55,181
   Other current assets                                                                         -                        3,250
                                                                                    --------------
                                                                                                               ----------------
           Total current assets                                                           240,037                      337,702
                                                                                    --------------             ----------------

Property and equipment, net (Note 4)                                                       35,191                       68,512
Other assets                                                                                4,432                       12,651  
                                                                                    --------------             ----------------

           Total  assets                                                            $     279,660             $        418,865

            LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)                                                      
===============================================================================
Current liabilities:
     Cash overdraft                                                                 $           -             $          1,432
     Notes payable                                                                              -                      101,000
     Accounts payable                                                                     352,346                      439,228
     Deferred revenue (Note 5)                                                            101,000                            -
     Accrued expenses                                                                     179,943                      220,694
     Accrued severance costs (Note 10)                                                     68,704                      103,634
     Current portion of capital lease obligations (Note 7)                                 11,731                       12,161
                                                                                    --------------
                                                                                                               ----------------
           Total current liabilities                                                      713,724                      878,149
                                                                                    --------------             ----------------

Capital lease obligations (Note 7)                                                         16,908                       28,639
Suborndinated notes payable (Note 16 )                                                    283,688                            -
Accrued severance costs (Note 10)                                                               -                       69,474
                                                                                    --------------
                                                                                                               ----------------
           Total liabilities                                                            1,014,320                      976,262
                                                                                    --------------             ----------------


                                                                                                                
Stockholders' equity (deficit)  (Note 11)
    Series A Preferred stock, $.01 par value; authorized 1,000,000                   
          shares;  315,238   issued and outstanding at December 31,                  
           1996 and 1995, respectively.                                                     3,152                        3,152
    Common stock, $.01 par value; 30,000,000 shares authorized:                                                 
          1,778,646 and 1,338,646 issued and outstanding at
          December 31, 1996 and 1995, respectively                                         17,786                       13,386
    Additional paid- in capital                                                         8,434,353                    8,423,428
    Accumlated deficit                                                                 (9,189,951)                  (8,997,363)
                                                                                    --------------
                                                                                                               ----------------
           Total stockholders' equity (deficit)                                          (734,660)                    (557,397)
                                                                                    --------------             ----------------
                                                                                                                
             Total liabilities and stockholders' equity                            $      279,660             $         418,865
                                                                                    ==============
                                                                                                                          

The accompanying notes are an integral part of the financial statements.

</TABLE>


                                      F-3



<TABLE>
<CAPTION>

                      XEROGRAPHIC LASER IMAGES CORPORATION

                            Statement of Operations

                                                                                       Years Ended Decemeber 31,
                                                                 -----------------------------------------------------------------
<S>                                                                    <C>                       <C>                     <C> 
                                                                             1996                     1995                   1994
                                                                 -----------------       ------------------       ----------------
                                                                                                                   
Revenues:
   Product revenues                                           $           200,368     $            397,550     $        1,342,212   
   Contract and license revenues                                          698,250                  700,000                    - -
                                                                 -----------------       ------------------       ----------------
                 Total revenues                                           898,618                1,097,550              1,342,212
                                                                 -----------------       ------------------       ----------------

Cost and expenses:                                                                                                 
   Cost of product revenues                                               176,886                  294,851              1,580,052
   Cost of contract and license revenue                                    81,554                  202,015                    - -
   Research and development                                               287,748                  331,279                398,026
   Selling and marketing                                                   42,942                  117,896                794,873
   OEM development                                                            - -                      - -                497,867
   General and administrative                                             456,156                  358,040              1,015,624
                                                                 -----------------       ------------------       ----------------
                 Total cost and expenses                                1,045,286                1,304,081              4,286,442   
                                                                 -----------------       ------------------       ----------------
Loss from operations                                                     (146,668)                (206,531)            (2,944,230)
                                                                 -----------------       ------------------       ----------------

Other income (expense)
   Interest expense                                                       (49,252)                 (24,655)              (199,134)
   Interest income                                                            - -                      396                 26,916
   Other income                                                             3,332                    7,333                    - -
                                                                 -----------------       ------------------       ----------------
                        Total other expense, net                          (45,920)                 (16,926)              (172,218) 
                                                                 -----------------       ------------------       ----------------

Net loss                                                      $          (192,588)    $           (223,457)    $       (3,116,448) 
                                                                 =================       ==================       ================

Net loss per common share                                     $             (0.12)    $              (0.18)    $            (3.44) 
                                                                                          
Weighted average common and common
         equivalent shares outstanding                                  1,565,105                1,255,314                906,143

</TABLE>
                                                                  

The accompanying notes are an integral part of the financial statements.




                                      F-4




<TABLE>
<CAPTION>
                                                                      XEROGRAPHIC LASER IMAGES CORPORATION

                                                              Statements of Changes in Stockholders' (Deficit) Equity

                                                                                                                                   
                                               Preferred Stock            Common Stock                                     Total 
                                         -------------------------  ------------------------   Additional              Stockholders'
                                           Number of                  Number of                 Paid-in    Accumulated   (Deficit)
                                         Shares Issued   Par Value  Shares Issued  Par Value    Capital     Deficit       Equity
                                         -------------   ---------  -------------  ---------   ----------  -----------  ------------
<S>                                           <C>             <C>         <C>         <C>          <C>         <C>           <C>
Balance at December 31, 1993                   -               -       3,817,174     38,172     5,503,247   (5,657,458)    (116,039)

Issuance of common stock                                                                                                           
  for bridge financing                         -               -         100,000      1,000       221,082         -         222,082

Issuance of common stock in exchange
  for conversion of long term debt             -               -          40,000        400        79,600         -          80,000
 
Issuance of common stock in exchange
  for conversion of bridge financing           -               -          50,000        500        99,500         -         100,000

Issuance of common stock in exchange
  for extension of long term note              -               -          15,000        150        18,600         -          18,750

Issuance of Series A convertible
  preferred stock                           850,000           8,500         -          -        2,461,403         -       2,469,903

Conversion of Series A Preferred Stock
  into common stock                        (518,442)         (5,184)   2,592,210     25,922       (20,738)        -            -
                                                                                                                                   
Reverse common stock split                                                                                                         
  on November 29, 1994                         -               -      (5,539,361)   (55,394)       55,394         -            -

Net loss                                       -               -            -          -             -      (3,116,448)  (3,116,448)
                                          

Balance at December 31,1994                 331,558           3,316    1,075,023     10,750     8,418,088   (8,773,906)    (341,752)

Conversion of Series A Preferred Stock
  into common stock                         (16,320)           (164)      13,623        136            28         -            -

Issuance of common stock to key
  employees in lieu of full cash
  compensation                                 -               -         250,000      2,500         5,312         -           7,812

Net loss                                       -               -            -          -             -        (223,457)    (223,457)
                                            
Balance at December 31, 1995                315,238           3,152    1,338,646     13,386     8,423,428   (8,997,363)    (557,397)

Issuance of common stock to key
  employees in lieu of full cash
  compensation                                 -               -         440,000      4,400        10,925         -          15,325

Net loss                                       -               -            -          -             -        (192,588)    (192,588)
                                            
Balance at December 31,1996                 315,238        $  3,152    1,778,646   $ 17,786   $ 8,434,353  $(9,189,951)   $(734,660)

</TABLE>



The accompanying notes are an integral part of the financial statements.





                                      F-5




<TABLE>
<CAPTION>
                      XEROGRAPHIC LASER IMAGES CORPORATION
                            Statement of Cash Flows


                                                           Years Ended December 31,             
                                                                                                
                                                      1996            1995            1994      
                                                 ----------      ----------    ------------                                         
<S>                                                  <C>             <C>             <C>
                                                                                                
Cash flows from operating activies                                                              
 Net loss                                        $ (192,588)    $ (223,457)    $ (3,116,448)    
 Adjustments to reconcile net loss to                                                           
  net cash used in operating activities:                                                        
 Restructuring charge                                     -              -           33,750     
 Write-offs                                               -              -          305,143     
 Inventory write-offs                                30,516         41,855          174,267     
 Write-offs of fixed assets                               -          3,471          114,686     
 Bad debt adjustment & sales adjustment                   -              -          656,590     
 Depreciation and amortization                       33,321         73,766          293,692     
 Issuance of common stock for bridge                                                            
  financing                                               -              -          157,200     
 Issuance of common stock for services                                                          
  rendered                                           15,325          7,812                -     
 (Increase) decrease in operating assets:                                              
  Accounts receivable                               258,957       (222,702)        (299,590)    
  Inventory                                          24,665         75,821         (259,383)    
  Other assets                                       11,469          6,281          (24,389)    
Increase(decrease) in operating liabilities:                                     
  Accounts payable                                  (86,882)       118,854         (180,553)
  Deferred revenue                                  101,000              -                -
  Accrued expenses                                  (27,063)       186,467          (78,087)
  Accrued severence costs                          (104,404)      (128,221)        (112,038)
  Due to related parties                                  -              -          (56,703)
                                                 ----------     ----------     ------------                                        
Net cash provided (used) by operating activities     64,316        (60,053)      (2,391,863)
                                                 ----------     ----------     ------------
Cash flows from investing activities:
  Purchase of property and equipment                      -              -          (15,046)
  Capitalized software                                    -              -          (60,918)
                                                 ----------     ----------     ------------
Net cash used by investing activities                     -              -          (75,964)
                                                 ----------     ----------     ------------

Cash flows from investing activities:
 Proceeds from issuance of preferred stock                -              -        2,469,903
 Receipts of notes payable                          204,500         26,000                -
 Payments of notes payable                          (35,500)             -         (150,000)
 Payments of related party notes payable                  -              -         (205,000)
 Payments under capital lease obligations           (12,161)       (43,253)        (148,168)
 Net Proceeds from bridge financing                       -              -          500,000
 Cash overdraft                                      (1,432)         1,432                -
                                                 ----------     ----------     ------------
Net cash provided (used) by financing activities    155,407        (15,821)       2,466,735
                                                 ----------     ----------     ------------

Net increase (decrease) in cash                     219,723        (75,874)          (1,092)
Cash at beginning of period                               -         75,874           76,966
                                                 ----------     ----------     ------------
Cash at end of period                            $  219,723     $        -     $     75,874
                                                 ==========     ==========     ============

Supplemental disclosure of cash flow information:
  Interest paid                                  $   45,616     $   20,340     $     24,102

</TABLE>


    The accompanying notes are an integral part of the financial statements.




                                      F-6





                      XEROGRAPHIC LASER IMAGES CORPORATION

                          NOTES TO FINANCIAL STATEMENTS



1. Nature of Business and Basis of Presentation

     Xerographic  Laser Images  Corporation  (the "Company") was founded in June
1989 to develop,  manufacture and market a proprietary technology which improves
the quality of output from laser printers.

     For the fiscal years ended  December 31, 1996,  1995 and 1994,  the Company
had net losses of $192,588, $223,457 and $3,116,448,  respectively.  The Company
had a working capital deficit of $473,687 and accumulated deficit of $734,660 at
December 31, 1996.

     The Company has no current plans to undertake a debt or equity financing in
1997.  Funds for  development  efforts  will come from  current  or  anticipated
licensing  and royalty  fees.  If the  Company is unable to fund its  operations
through cash flow,  the Company's  development  efforts and  operations  will be
materially adversely effected.

    Management  believes that progress has been made in reducing expenses and in
obtaining additional  development  partnership agreements which will enhance the
Company's  chances of operating on a profitable  basis.  Despite  these  factors
there remains  substantial  doubt about the  Company's  ability to continue as a
going  concern.  The financial  statements do not include any  adjustments  that
might be necessary should the Company be unable to continue as a going concern.



2.  Summary of Significant Accounting Policies

Use of Estimates

    In preparing  financial  statements in conformity  with  generally  accepted
accounting principles,  management is required to make estimates and assumptions
that affect the  reported  amounts of assets and  liabilities  as of the balance
sheet  date and the  amounts  of  revenues  and  expenses  recorded  during  the
reporting  period.  Actual  results  could  differ  from those  estimates.  Such
estimates  primarily  relate to the fair values of  financial  instruments,  the
allowance for doubtful accounts, the valuation allowance for deferred tax assets
and the depreciable lives of property and equipment.



                                      F-7




Revenue Recognition

     Revenues  from product  sales are  recognized at the time of shipment or in
accordance  with  contractual  acceptance  terms.   Research,   development  and
licensing  contract  revenues are recognized when the related costs are incurred
and performance criteria in the contract are met.

Inventory
       Inventory is stated at the lower of cost (first in, first out) or market.
During 1996,  all  remaining  board  product  inventory  became  obsolete due to
changing technology, and was written off.

Property and Equipment

    Purchased  property  and  equipment  are recorded at cost.  Depreciation  is
recorded using the  straight-line  method over the estimated useful lives of the
related  assets,  which is generally five years.  Property and equipment  leased
under capital leases are stated at cost and are amortized over the lesser of the
lease term or estimated useful life.

    Maintenance and repairs are charged to expense as incurred.  When assets are
retired  or  otherwise  disposed  of,  the assets  and  related  allowances  for
depreciation and amortization are eliminated from the accounts and any resulting
gain or loss, if any, is reflected in the results of operations.

Research and Development

     Research and development costs are expensed as incurred.

Product Warranty Costs

     The  Company's  warranty  period on sales of its product is  generally  one
year.  Estimated  future costs for initial  product  warranties  are  considered
immaterial.

Income Taxes

     Deferred tax assets and liabilities are recorded for temporary  differences
between the financial  statement and tax bases of assets and  liabilities  using
the currently  enacted  income tax rates expected to be in effect when the taxes
are actually  paid or  recovered.  A deferred tax asset is also recorded for net
operating loss and tax credit  carryforwards to the extent their  realization is
more likely than not.  The deferred  tax expense for the period  represents  the
change in the deferred tax asset or liability  from the  beginning to the end of
the period.

Net Loss Per Common Share

     Net loss per  common  share is  computed  based upon the  weighted  average
number of common shares  outstanding.  Common share 




                                      F-8



equivalents  are not  included  in the per share  calculations  as the effect of
their inclusion would be antidilutive.  The net loss per common share for fiscal
years  presented  have been  adjusted  to reflect  the six for one common  stock
reverse stock split as described in Note 11.

Organization Costs

     Certain costs relating to the  organization of the Company were capitalized
and were amortized over 60 months using the straight-line method.

Patent and Trademark Application Costs

     Certain  costs  relating  to  obtaining  patents  and  trademarks  for  the
Company's technology and products have been capitalized.  Amortization commences
when the patent or  trademark  is allowed and granted and is  amortized  over 60
months, which is the estimated useful life of the asset.

Capitalization of Software Costs

     The Company follows Statement of Financial Accounting Standard ("SFAS") No.
86,  "Accounting  for the Costs of  Computer  Software  to be Sold,  Leased,  or
Otherwise  Marketed." The remaining  balance of  Capitalized  Software costs was
written off in 1994.  Prior to the  write-off,  software costs incurred prior to
the  establishment  of  technological  feasibility  were charged to research and
development  expense.  Software  production  costs  incurred  subsequent  to the
establishment  of technological  feasibility were capitalized  until the product
was available  for general  release to customers.  Amortization  of  capitalized
software costs was charged to cost of sales over the estimated economic lives of
the related products, beginning at their initial shipment date.

Stock-Based Compensation

      In October 1995, the Financial  Accounting Standards Board ("FASB") issued
"SFAS" No.  123,  "Accounting  for  Stock-Based  Compensation."  This  Statement
encourages  all  entities to adopt a fair value based method of  accounting  for
stock  compensation,  whereby  compensation  cost is  measured at the grant date
based on the value of the award and is recognized over the service period, which
is usually the vesting period.  However, it also allows an entity to continue to
measure  compensation  cost for employee  plans using the intrinsic  value based
method of accounting  prescribed by Accounting  Principles Board ("APB") Opinion
No. 25, "Accounting for Stock Issued to Employees," whereby compensation cost is
the excess,  if any, of the quoted  market  price of the stock at the grant date
(or other  measurement date) over the amount an employee must pay to acquire the
stock.  Entities  electing to continue to apply APB Opinion  No.25 for  employee
stock-based  compensation  must make pro forma  disclosures  of net  income  and
earnings  per share,  as if the fair value based method of  accounting  had been
applied.



                                      F-9




       Generally,  stock options  issued under the  Company's  stock option plan
have no  intrinsic  value at the grant  date,  and under APB  Opinion  No. 25 no
compensation  cost  is  recognized.   The  Company  will  continue  its  current
accounting  treatment  for  employee  stock  options  and  make  the  pro  forma
disclosures  proscribed by this Statement.  Stock options granted to individuals
not classified as employees were immaterial during 1996.

3.  Income Taxes

     The Company has  generated  operating  loss  carryforwards  for federal and
state income tax and federal  alternative  minimum tax purposes of approximately
$8,710,000 for the period June 9, 1989  (inception)  through  December 31, 1996.
These net  operating  losses  will expire at various  dates  through  2011.  The
Company has also generated  research and  development  credits of  approximately
$211,000  for the period June 9, 1989  (inception)  through  December  31, 1996,
which expire at various dates through 2011.  Utilization  of these net operating
loss  carryforwards  and  research  and  development  credits will be subject to
annual limitations based on Internal Revenue Code provisions relating to changes
in the Company's ownership.

     The  approximate  tax effect of each type of  temporary  difference  before
allocation of the valuation allowance is as follows:

                                                       December 31,

Deferred tax assets:                            1996                   1995

  Net operating loss carryforwards . . .     $3,484,000            $3,460,000
  Tax credit carryforwards . . . . . . .        211,000               181,000
  Allowance for doubtful accounts. . . .          2,000                 9,200
  Accrued Restructuring Costs  . . . . .         27,500                76,400
                                                 ------                ------

Total deferred tax asset . . . . . . . .      3,724,500             3,726,600

Valuation allowance  . . . . . . . . . .     (3,724,500)           (3,726,600)
                                              ---------             ---------

Net deferred tax asset . . . . . . . . .     $   --                   $   --
                                              =========               =======



     Due to the uncertainty  surrounding the timing of realizing the benefits of
its  favorable tax  attributes  in future tax returns,  the Company has placed a
100% valuation allowance against deferred tax assets.


4. Property and Equipment

Property and equipment consists of the following:



                                      F-10




                                                December 31,        December 31,
                                                    1996                1995

Equipment . . . . . . . . . . . . . .            $121,740             121,740
Capitalized lease equipment . . . . .             368,964             368,964
                                                  -------             -------
                                                  490,704             490,704
  
Less accumulated depreciation                   (455,513)
 and amortization . . . . . . . . . .                               (422,192)
 
Property and equipment, net . . . . .            $ 35,191            $ 68,512
                                                 ========            ========



5. Deferred Revenue
     During November and December 1996 the Company received revenue for contract
   and licensing  agreements that included fees for support engineering services
   that will be performed in 1997.

6. Stock Option Plan

     The Company maintains two stock options plans (the "1990 Stock Option Plan"
and the "1992  Stock  Option  Plan")  whereby the Board of  Directors,  at their
discretion,  may issue either incentive stock options or nonqualified options to
employees  and   nonqualified   options  to  consultants,   directors  or  other
nonemployees.

     Incentive  stock  options  may not be granted at a price less than the fair
market  value of the shares at the grant date (or less than 110% of fair  market
value in the case of  employees  or  officers  holding 10% or more of the voting
stock) while the  nonqualified  options may not be granted at a price lower than
the  lesser of 50% of the fair  market  value of the shares at the grant date or
the book  value of the shares as of the end of the  fiscal  year of the  Company
immediately  preceding the date of the grant. All grants as of December 31, 1996
were at fair market value or greater.  The options generally vest ratably over a
period of zero to five years.  Incentive  stock  options  granted under the plan
must expire not more than 10 years from the date of grant and not more than five
years in the case of incentive  stock options  granted to an employee or officer
holding  10% or more  of the  voting  stock  of the  Company.  All  options  not
exercised prior to the expiration date automatically expire.




                                      F-11




The following table summarizes all stock option activity:






                                                       Weighted
                                                       Average
                                  Number of Options    Exercise
                                                       price


Outstanding at December 31, 1993        370,583        $1.41-3.88
                                        =======

Granted........................       1,029,417               .25    
Cancelled......................        (370,583)        1.41-3.88
Terminated.....................        (201,500)              .25
                                        -------


Outstanding at December 31, 1994
giving effect to reverse stock
split on November 29, 1994              137,986         1.99
  Granted........................       287,000          .03125
  Canceled.......................       (74,381)        1.50
  Terminated.....................       (25,638)        1.50
                                         ------

Outstanding at December 31, 1995        324,967        $ .41
                                        =======

   Granted.......................       125,500          .02
   Canceled......................       (10,417)         .03125
   Terminated....................        (1,176)        1.50
                                          -----

 Outstanding at December 31, 1996       438,874        $ .30
                                        =======

 At December 31, 1996, 8,936 shares are available for future grants.


Information  pertaining  to  options  outstanding  at  December  31,  1996 is as
follows:
                    Options Outstanding

                                   Weighted Avg.
                                   Remaining
Range of           Number          Contractual         Weighted Avg.
Exercise Prices   Outstanding      Life                Exercise Price
- ---------------   -----------      ------------        --------------
$.01-$.10         402,500          2.9 years           $.03
$1.50-$3.00        30,375          2.4 years           $1.54
$10.50-$22.50       5,999          1.9 years           $12.16
                  438,874          2.8 years           $.30




                                      F-12



                     Options Exercisable
                     -------------------

Range of            Number                Weighted Avg.
Exercise Prices   Exercisable            Exercise Price
- ---------------   -----------            --------------
$.01-$.10           160,834                   $.03
$1.50-$3.00          30,375                  $1.54
$10.50-$22.50         5,999                 $12.16
                    197,208                 $  .63


The Company applies APB Opinion 25 and related interpretations in accounting for
its employee option and warrant grants.  Accordingly,  no compensation  cost has
been recognized.  Had compensation  cost been determined based on the fair value
at the grant  dates for awards  under  those  plans  consistent  with the method
prescribed by SFAS No. 123, the Company's net loss and net loss per common share
would have been increased to the pro forma amounts indicated below:

                                          Years Ended December 31,
                                          1996               1995
                                       ----------         ----------
Net loss:   As Reported                $(192,588)         $(223,457)
            Pro Forma                   (194,138)          (251,426)

Net loss             As Reported           (.12)              (.18)
per common share:    Pro Forma             (.12)              (.20)

     The fair value of each option or warrant  granted is estimated on the grant
date  using  the  Black-Scholes  option  pricing  model.  Due to the  historical
volatility of the Company's stock price, the fair value of the option or warrant
is  generally  equal to the fair value of the  underlying  stock.  The  weighted
average  fair value of options  granted as of the grant  dates was $.01 and $.03
for 1996 and 1995 respectively.


7. Commitments

     The Company  leases its facilities and certain  equipment  under  operating
lease  agreements  which expire on various dates through  1999.  Rental  expense
incurred under these  agreements  was $36,100,  $56,179 and $80,762 during 1996,
1995, and 1994 respectively. The Company has entered into various capital leases
for office  equipment,  the net book value of which were  $28,638,  $51,915  and
$61,458 at December 31, 1996, 1995 and 1994, respectively.

     The future  minimum  annual  lease  obligations  under these leases for the
respective years ending December 31 are as follows:




    
                                  F-13



                                            Capital Leases   Operating Leases

1997                                         $ 18,528        $   42,700
1998                                           18,528            37,830
1999                                            8,249            12,610
                                               -----             ------

 Total Obligation                              45,305            97,074
                                                                 ------

Less amount representing interest             (16,666)

Present value of minimum lease payments        28,639

Less current portion                          (11,731)

Long-term obligation                          $16,908





8.  Related Party Transactions

     In July  1989,  the  Company  entered  into an  Agreement  with the  Carley
Corporation,  a company founded by Dr. Adam L. Carley, a founder of the Company,
pursuant to which the Company acquired an exclusive worldwide license to certain
technology  (the "Carley  Technology")  for the  printing of text,  graphics and
photographic  images.  In  consideration  therefore,  the Company issued 268,040
shares of common stock valued at $.01 per share to the two  stockholders  of the
Carley  Corporation  and agreed to pay royalties equal to 5% of cash received in
connection with sales of hardware or software products  incorporating the Carley
Technology and 33 1/3% on all related  technology  sublicensed to third parties,
up to  $2,400,000.  The Carley  Corporation  has agreed that upon payment of the
total royalty amount it will assign all rights, title and interest to the Carley
Technology,  including any  improvements  or future  developments  on the Carley
Technology,  to the  Company.  Upon the  assignment  the  Company  has agreed to
sublicense the Carley Technology to the Carley Corporation,  on an exclusive and
royalty-free  basis,  for retail  services  including but not limited to stores,
kiosks and booths for purposes of picture making and picture reproduction.

     In December  1993,  the Company and Carley  Corporation  amended the Carley
Agreement such that Carley  Corporation shall be paid minimum royalties of : (i)
$75,000 in fiscal year 1994; (ii) $82,500 in fiscal year 1995; and (iii) $90,000
in fiscal  year 1996.  Additionally,  Carley  Corporation  will be  entitled  to
additional  royalties  not to exceed  $225,000 in each of these years based on a
percentage of net profit after interest, taxes and the minimum royalty payments.



                                      F-14




     Royalties expensed under the Carley Agreement were  approximately  $90,000,
$82,500  and  $104,000  for the years ended  December  31,  1996,  1995 and 1994
respectively.  Cumulative  royalties  expensed in connection with this agreement
were $517,585 through  December 31, 1996.  Accrued Expenses at December 31, 1996
includes $103,375 due under the Carley Agreement.

     Effective  January 1, 1997,  the Company and the Carley  Corporation  again
amended the Carley  Agreement to provide a royalty of 15% of cash  receipts from
sales and licenses of products  incorporating the Carley Technology,  in lieu of
the previous royalty rate of 5% on boards and 33 1/3% of license fees.



9.  Capitalized Software Costs

     The  Company  previously  capitalized  software  costs in  connection  with
certain  printer  related  products.  During  1994,  the Company  wrote down the
balance of  capitalized  software  costs by  $305,143,  which was the  remaining
balance.

10.  Severance Charges

     On November  11,  1993,  the Company  recorded  approximately  $380,000 for
severance  charges  relating to the  resignation of the Company's  President and
Vice President of Engineering.  The cash payments  associated with these charges
will extend  through  November 1997. The Company paid $104,404 and $89,908 under
these agreements during 1996 and 1995, respectively.

11.  Capital Stock
     Series A Preferred Stock

     On February 22, 1994,  the Company  completed an offering of 850,000 units,
each  consisting  of one share of Series A Convertible  Preferred  Stock and one
Class A redeemable  Common Stock  Purchase  Warrant.  Each share of  convertible
preferred stock is convertible into five shares of the Company's Common Stock at
any time after 90 days from the date of issue.  During 1995 and to date, 534,762
shares of Series A Convertible  Preferred Stock have been converted into 445,635
shares of  Common  Stock.  At  December  31,  1996,  315,238  shares of Series A
Preferred Stock remained outstanding. To date, there have been no dividends paid
or accrued on Series A  Preferred  Stock.  Series A Preferred  stockholders  are
entitled to an annual cumulative dividend of 9% provided net income exceeds 150%
of the aggregate dividend payable, and in any year in which the Company does not
have net  earnings  after  taxes in  excess  of 150% of the  aggregate  dividend
payable, no dividend shall be paid.

    Common Stock

     On January 20, 1993, the Company  completed an initial  public  offering of
775,000 units,  each consisting of two shares of Common Stock and one redeemable
Common Stock Purchase Warrant.  On November



                                      F-15




29, 1994, the Company held a Special Meeting of the  Stockholders and authorized
a 1-for-6  reverse  stock split of the Company's  Common Stock.  At December 31,
1996 there were 1,778,646  shares of Common Stock  outstanding.  During 1996 and
1995  the  Company   awarded   440,000  and  250,000  shares  of  Common  Stock,
respectively, to key employees in lieu of cash compensation.


    Warrants

     In connection  with the Company's  initial public offering in January 1993,
the Company issued 775,000 Common Stock Purchase  Warrants ("IPO Warrants") at a
price of $5.00 per share if exercised  prior to July 12, 1995,  and at $7.00 per
share if exercised thereafter until January 12, 1998. The Company also issued to
Thomas  James  Associates,  Inc.,  a warrant  (the  "Underwriter's  Warrant") to
purchase 77,500 Units,  each Unit consisting of two shares of Common Stock,  and
one IPO Warrant.  The  Underwriter's  IPO Warrant is exercisable for a four year
period commencing January 20, 1994, at an exercise price of $8.45 per unit.

     In connection  with the Company's  offering of Series A Preferred  Stock in
February  1994,  the  Company  issued  850,000  Class A Warrants,  each  warrant
allowing  for the purchase of one share of Common  Stock,  at a price of $1.1375
per share if  exercised  prior to August 22,  1997,  and at $1.3125 per share if
exercised  thereafter until February 22, 1999. The Company also issued to Thomas
James Associates, Inc., a warrant to purchase 85,000 Units, each Unit consisting
of five shares of Common Stock, and one Class A Warrant. The Underwriter's Class
A Warrant is exercisable for a four year period commencing February 20, 1994, at
an exercise price of $4.80 per Unit.

     The  exercise  price and the number of shares of Common  Stock  purchasable
upon the exercise of the IPO,  Class A and  Underwriter  Warrants are subject to
adjustment  upon the occurrence of certain events,  including  stock  dividends,
stock splits,  combinations or reclassifications of the Common Stock, or sale by
the Company of shares of its Common  Stock at a price below the then  applicable
exercise price of the Warrants. Additionally, an adjustment would be made in the
case of a reclassification or exchange of Common Stock,  consolidation or merger
of the Company with another  corporation or sale of all or substantially  all of
the assets of the Company in order to enable Warrant holders to acquire the kind
and the number of shares of stock or other securities or property  receivable in
such  event by a holder of the  number of shares  of Common  Stock  there  might
otherwise have been purchased upon the exercise of the Warrant. No adjustment to
the exercise price of the Warrants will be made for dividends  (other than stock
dividends),  if any, paid on the Common Stock or for securities  issued pursuant
to the  Company's  Stock Option  Plans or other  employee  benefit  plans of the
Company.

     Giving effect to the events during 1994, 1995, and 1996, the holders of IPO
Warrants  are  entitled to purchase  .91 share of Common  Stock for each Warrant
held at a price of $7.38 per share until



                                      F-16



January 12,  1998;  the holders of Class A Warrants are entitled to purchase .43
share of Common Stock for each warrant held at a price of $2.62 until August 22,
1997, and at $3.06 per share until February 22, 1999;  Underwriter's IPO Warrant
entitles the Underwriter to purchase  23,302 units,  consisting of two shares of
Common Stock and one Common Stock Purchase Warrant at a price of $22.14; and the
Underwriters  Class A Warrant  entitles the Underwriter to purchase one share of
Common Stock at a price of $15.72.

     The Company  issued  warrants to various  lenders in 1992 which expire five
years from the date of issue, of which,  5,990,  1,777 and 8,319 warrants remain
outstanding at December 31, 1996, at an exercise price of $5.88, $8.46 and $5.88
per share, respectively.


     At December 31, 1996, the Company had the following  shares of Common Stock
reserved in the following amounts:

Reserved For:                              Number of Shares
                                        
Employee Stock Options                         447,810
IPO Warrants                                   701,468
Underwriter's IPO Warrants                      70,147
Class A Warrants                               362,984
Underwriter's Class A Warrants                  36,298
Lender's Warrants 1992*                         16,075
Lender's Warrants 1995*                        225,000
Lender's Warrants 1996*                        593,462
Convertible Preferred Shares                   262,698
Other Warrants                                 383,665
                                                  ----
                                   Total     3,099,607
* Warrants issued to lenders        
  including insiders

12.  Export Revenues

     The Company  currently  operates in one industry  segment.  Export  product
revenues are generated predominantly from Europe and accounted for approximately
19%,  16%  and 9% of  total  revenues  in  fiscal  years  1996,  1995  and  1994
respectively.


13.  Significant Customers

     For the year ended  December 31, 1996,  1995 and 1994,  the Company did not
have any customers that accounted for greater than 10% of total product revenue.
One customer  accounted for 72% of total  contract and license  revenues in 1996
and 59% in 1995.

14.  Other Income Statement Information

     Advertising costs for the years ended December 31, 1996, 1995 and 1994 were
$6,704, $1,905 and $48,440 respectively.




                                      F-17





15. Supplementary Cash Flow Information

     Accrued  interest  converted  to  subordinated  notes  payable  amounted to
$13,688. Noncash financing and investing activities are as follows:



                                          Years Ended December 31,
                                         1996       1995        1994
Assets acquired and obligations
     incurred resulting from capital
     lease obligations                  $  -          -       $61,458

Issuance of common stock for
     services rendered                  15,325     7,812         -


Issuance of common stock in
     connection with bridge financing      -          -       322,082

Issuance of common stock in
     exchange for conversion of
     long term debt                        -          -        98,750

Accrued interest converted to           13,688        -          -
     subordinated notes payable


16. Subordinated Notes Payable


     On May 31, 1996, the Company raised $283,688 in a limited private  offering
to accredited investors of subordinated  nonrecourse  promissory notes. Included
in this amount was $13,688 of accrued interest and $75,000 of outstanding  debt.
In addition to a note, each subscriber  received for each dollar invested a five
year warrant to purchase two shares of the Company's Common Stock at an exercise
price of $.01 per share.  Principal  and  interest  will be  repaid,  if at all,
solely from the  Company's  pre-tax  earnings  for each of the five fiscal years
commencing with the fiscal year ending December 31, 1996. Payments, if any, will
be made  annually  to the  holders  of the notes  within  thirty  days after the
Company files its Form 10-KSB or its then  equivalent  form with the  Securities
and  Exchange  Commission.  Such  annual  payments  shall  not  exceed,  in  the
aggregate,  approximately 14% of the Company's  pre-tax earnings,  and shall not
exceed over the five year term of the notes, three times the principal amount of
the notes.

      The Company issued 593,462 warrants in connection with the offering.



                                      F-18




17.  Factoring Agreement

        On December 21, 1995, the Company  entered into a financing  arrangement
with Silicon Valley  Financial  Services,  a division of Silicon Valley Bank, to
borrow against the Company's outstanding receivables. The advances bear interest
at a monthly  rate of 2.5% and require an advance fee of 1%. As of December  31,
1996, there were no receivables with Silicon Valley Bank.


18.  Significant risks and uncertainties

     In the normal  course of business,  the Company is exposed to certain risks
and uncertainties which could have an impact on the Company's operations.

Patent protection
     The  Company  protects  its  products  and  technology  through  the use of
patents.  There can be no assurance  that any patent granted will be enforceable
or provide meaningful protection from competitors.

Foreign customers
     The Company derives a portion of its revenues from international sales (See
Note 11). The Company  could be adversely  affected by changes in foreign  laws,
regulations, tariffs, and taxes.



                    [THIS SPACE IS INTENTIONALLY LEFT BLANK]



                                      F-19




<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     (Replace this text with the legend)
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   12-Mos
<FISCAL-YEAR-END>                              Dec-31-1996
<PERIOD-START>                                 Jan-01-1996
<PERIOD-END>                                   Dec-31-1996
<CASH>                                         219,723
<SECURITIES>                                   0
<RECEIVABLES>                                  25,314
<ALLOWANCES>                                   5,000
<INVENTORY>                                    0
<CURRENT-ASSETS>                               240,037
<PP&E>                                         490,704
<DEPRECIATION>                                 455,512
<TOTAL-ASSETS>                                 279,660
<CURRENT-LIABILITIES>                          713,724
<BONDS>                                        0
                          0
                                    3,152
<COMMON>                                       17,786
<OTHER-SE>                                     0
<TOTAL-LIABILITY-AND-EQUITY>                   279,660
<SALES>                                        200,368
<TOTAL-REVENUES>                               898,618
<CGS>                                          176,886
<TOTAL-COSTS>                                  301,382
<OTHER-EXPENSES>                               743,904
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             49,252
<INCOME-PRETAX>                                (192,588)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (192,588)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (192,588)
<EPS-PRIMARY>                                  (.12)
<EPS-DILUTED>                                  (.12)
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission